以下、添付の図面を参照して本発明の実施形態について具体的に説明するが、当該実施形態は本発明の原理の理解を容易にするためのものであり、本発明の範囲は、下記の実施形態に限られるものではなく、当業者が以下の実施形態の構成を適宜置換した他の実施形態も、本発明の範囲に含まれる。
しかしながら、上記構造式(I)からなる化合物は、セラミドとの類似構造性がほとんどないため、CERT以外へのoff target効果をHPA-12よりも大幅に低減できる。
本実施形態にかかる医薬組成物は、医薬的に有効量の本実施形態にかかる新規化合物を含み、感染症を治療又は予防するための医薬組成物である。例えば、本実施形態にかかる新規化合物は、CERTの機能を阻害してスィンゴ脂質の合成を阻害するため、HCVゲノム複製阻害だけでなく粒子形成あるいは感染過程も阻害可能である。そのためHCVを治療又は予防するための医薬組成物として使用できる。
本実施形態にかかる医薬組成物は、医薬的に有効量の本実施形態にかかる新規化合物を含み、がんを治療又は予防するための医薬組成物である。例えば、化学療法剤に対して耐性を獲得したがん細胞のCERTを阻害すると、がん細胞はの化学療法剤に対する再感作(resensitization)を起こす。そのためがんを治療又は予防するための医薬組成物として使用可能である。
本発明の医薬組成物は、注射、急速注入、鼻咽頭吸収、皮膚吸収により、非経口的に、および経口的に投与し得る。非経口投与のための製薬上許容可能な担体調製物としては、滅菌、あるいは水性または非水性の溶液、懸濁液および乳濁液が挙げられる。非水性溶媒の例は、プロピレングリコール、ポリエチレングリコール、植物油、例えばオリーブ油、注射可能有機エステル、例えばエチルオレエートである。閉塞性包帯用の担体は、皮膚透過性を増大し、抗原吸収を増強するために用い得る。経口投与のための液体投薬形態は、液体投薬形態を含有するリポソーム溶液を包含し得る。
本発明の医薬組成物は、アジュバントを含有することも可能である。アジュバントは、特異的免疫応答を非特異的に増大するために用い得る物質である。アジュバントは、それらの粗製に基づいて、大まかにいくつかの群に分けられる。
下記合成法により本実施例にかかる化合物を合成した。
(1)A1〜A25の合成
A1〜A25の合成は下記合成法により合成した。
ここでL1(R1及びR2がともに水素原子)は市販品を使用した。
2-ethynyl-6-methylpyridine(L2)は、下記合成法により合成した。
2-ethynyl-3-methylpyridine(L3)は、下記合成法により合成した。
2-ethynyl-3-pentylpyridine(L4)は、下記合成法により合成した。
3-Iodobenzeneboronic acid pinacol ester(M1)は、下記合成法により合成した。
2-fluoro-5-iodobenzeneboronic acid pinacol ester(M2)は、下記合成法により合成した。
3-(tert-butyl)-5-iodobenzeneboronic acid pinacol ester(M3)、5-iodo-3-methylbenzeneboronic acid pinacol ester(M4)、及び、5-iodo-3-(trifluoromethyl)benzeneboronic acid pinacol ester(M5)は、下記合成法により合成した。
3-iodo-4-methylbenzeneboronic acid pinacol ester(M6)は、下記合成法により合成した。
3-Iodo-6-methylbenzeneboronic acid pinacol ester(M7)は、下記合成法により合成した。
3-Iodo-4-propylbenzeneboronic acid pinacol ester(M8)、3-Iodo-4-pentylbenzeneboronic acid pinacol ester(M9)、3-Iodo-4-isopropylbenzeneboronic acid pinacol ester(M10)、3-Iodo-4-isobutylbenzeneboronic acid pinacol ester(M11)、3-Iodo-4-heptylbenzeneboronic acid pinacol ester(M12)、及び、3-Iodo-4-octylbenzeneboronic acid pinacol ester(M13)は、下記合成法により合成した。
3-Iodo-4-cyclohexylbenzeneboronic acid pinacol ester(M14)、及び、3-Iodo-4-cyclopentylbenzeneboronic acid pinacol ester(M15)は、下記合成法により合成した。
4-Hydroxyethylsulfonylbromobenzene(R1)は、下記合成法により合成した。
合成したA1〜A25のNMRを下記に示す。
4'-(2-hydroxyethanesulfonyl)-3-(pyridin-2-ylethynyl)-1,1'-biphenyl (A1) 1H-NMR (CDCl3) δ: 8.65-8.63 (1H, m), 8.02-8.00 (2H, m), 7.86 (1H, dd, J = 2.3, 1.1 Hz), 7.79 (2H, dt, J= 8.8, 1.9 Hz), 7.72 (1H, td, J = 7.8, 1.9 Hz), 7.68-7.65 (1H, m), 7.62 (1H, tt, J = 5.0, 1.9 Hz), 7.56 (1H, dt, J = 7.9, 1.0 Hz), 7.50 (1H, t, J = 7.8 Hz), 7.28 (1H, ddd, J = 7.3, 4.7, 1.4 Hz), 4.06 (2H, dt, J = 10.9, 5.9 Hz), 3.42 (2H, dt, J = 4.1, 2.0 Hz), 2.97 (1H, t, J = 6.3 Hz).; 13C-NMR (CDCl3) δ: 56.4, 58.4, 88.4, 89.3, 123.0, 123.3, 127.2, 127.9, 128.0, 128.6, 129.3, 131.0, 132.1, 136.3, 137.9, 139.2, 143.1, 145.9, 150.1.
2-fluoro-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A2) 1H-NMR (CDCl3) δ: 8.63 (1H, dt, J= 4.6, 1.6 Hz), 8.03 (2H, dt, J = 8.7, 2.1 Hz), 7.79-7.76 (2H, m), 7.74-7.62 (3H, m), 7.55-7.46 (2H, m), 7.28 (1H, ddd, J = 7.4, 4.7, 1.5 Hz), 7.22 (1H, dd, J = 10.5, 8.7 Hz), 4.06 (2H, s), 3.42 (2H, td, J= 4.1, 2.0 Hz), 3.05 (1H, s).; 13C-NMR (CDCl3) δ: 56.3, 58.3, 87.4, 89.0, 116.9 (d, J = 23.0 Hz), 119.2 (d, J = 3.8 Hz), 123.1, 127.2 (d, J= 18.2 Hz), 128.3, 128.5 (d, J = 11.5 Hz), 130.0 (d, J = 3.8 Hz), 132.0 (d, J = 5.8 Hz), 134.1 (d, J = 8.6 Hz), 134.4 (d, J= 2.9 Hz), 136.3, 138.3, 140.6, 142.9, 150.1. 158.4, 161.0.
4'-(2-hydroxyethanesulfonyl)-3-(6-methylpyridin-2-yl)ethynyl-1,1'-biphenyl (A3) 1H-NMR (CDCl3) δ: 7.96 (2H, dd, J = 8.5, 5.3 Hz), 7.79 (1H, d, J = 5.0 Hz), 7.69 (2H, dd, J = 8.2, 5.0 Hz), 7.57 (3H, tt, J = 11.9, 4.7 Hz), 7.40 (2H, tt, J = 13.1, 4.7 Hz), 7.11 (1H, dd, J = 7.8, 5.0 Hz), 4.37 (1H, s), 4.06 (2H, q, J = 5.6 Hz), 3.46 (2H, q, J = 5.6 Hz), 2.53 (3H, d, J = 5.0 Hz).; 13C-NMR (CDCl3) δ: 23.9, 55.6, 58.0, 88.0, 88.9, 122.6, 122.7, 124.2, 127.4, 127.4, 128.2, 128.3, 128.9, 130.3, 131.4, 131.6, 136.4, 137.8, 138.7, 141.6, 144.9, 158.5.
2-fluoro-4'-(2-hydroxyethanesulfonyl)-5-(6-methylpyridin-2-yl)ethynyl-1,1'-biphenyl (A4) 1H-NMR (CDCl3) δ: 8.00 (2H, dt, J = 8.7, 1.8 Hz), 7.72 (3H, ddd, J = 12.8, 7.8, 1.8 Hz), 7.61 (2H, tt, J = 6.9, 3.3 Hz), 7.36 (1H, d, J= 7.3 Hz), 7.17 (2H, dt, J = 19.7, 6.2 Hz), 4.07 (2H, t, J = 5.7 Hz), 3.73 (1H, s), 3.46-3.43 (2H, m), 2.56 (3H, s).; 13C-NMR (CDCl3) δ: 24.2, 55.9, 58.2, 87.0, 88.9, 116.7 (d, J = 23.0 Hz), 119.1 (d, J = 3.8 Hz), 122.9, 124.3, 127.2 (d, J = 14.4 Hz), 127.7, 128.1, 129.7 (d, J = 3.8 Hz), 133.9 (d, J = 9.6 Hz), 134.2 (d, J = 3.8 Hz), 136.5, 138.3, 140.3, 141.8, 158.2, 158.8, 160.7.
3-tert-butyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A5) 1H-NMR (CDCl3) δ: 8.65 (1H, td, J= 2.5, 0.9 Hz), 8.03-8.00 (2H, m), 7.80 (2H, dt, J = 8.7, 1.8 Hz), 7.73-7.67 (3H, m), 7.61 (1H, t, J = 1.8 Hz), 7.57 (1H, dt, J = 7.8, 1.1 Hz), 7.27 (2H, tt, J = 5.7, 1.8 Hz), 4.06 (2H, q, J = 5.6 Hz), 3.42-3.40 (2H, m), 2.83 (1H, t, J = 6.2 Hz), 1.40 (9H, s).; 13C-NMR (CDCl3) δ: 31.2, 34.9, 56.4, 58.4, 88.7, 89.1, 122.8, 122.9, 125.3, 127.1, 127.9, 128.2, 128.6, 129.4, 129.6, 134.0, 136.3, 137.7, 139.1, 143.2, 146.6, 150.1, 152.4.
4'-(2-hydroxyethanesulfonyl)-3-methyl-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A6) 1H-NMR (CDCl3) δ: 8.63 (1H, dq, J= 5.0, 0.9 Hz), 8.02-7.99 (2H, m), 7.78 (2H, dd, J = 6.9, 1.8 Hz), 7.71 (1H, td, J = 7.8, 1.8 Hz), 7.66 (1H, s), 7.55 (1H, dt, J = 7.8, 1.1 Hz), 7.49 (1H, s), 7.42 (1H, s), 7.29-7.25 (1H, m), 4.06 (2H, q, J = 5.6 Hz), 3.41 (2H, td, J = 4.1, 2.0 Hz), 3.01 (1H, t, J = 6.2 Hz), 2.45 (3H, s).; 13C-NMR (CDCl3) δ: 21.3, 56.4, 58.4, 88.7, 88.9, 122.9, 123.0, 127.2, 128.0, 128.2, 128.4, 128.6, 128.8, 132.1, 132.7, 136.3, 137.7, 139.1, 139.2, 143.2, 146.1, 150.1.
4'-(2-hydroxyethanesulfonyl)-3-(pyridin-2-ylethynyl)-5-trifluoromethyl-1,1'-biphenyl (A7) 1H-NMR (CDCl3) δ: 8.67-8.66 (1H, m), 8.06 (2H, dt, J = 8.5, 2.1 Hz), 8.03 (1H, s), 7.93 (1H, s), 7.82 (3H, dt, J = 8.7, 1.8 Hz), 7.74 (1H, td, J = 7.6, 1.7 Hz), 7.58 (1H, dt, J = 7.8, 1.1 Hz), 7.32 (1H, ddd, J = 7.7, 4.9, 1.3 Hz), 4.07 (2H, dd, J = 10.5, 6.4 Hz), 3.42 (2H, td, J = 4.1, 2.0 Hz), 2.79 (1H, t, J = 6.2 Hz).; 13C-NMR (CDCl3) δ: 56.4, 58.4, 86.7, 90.7, 122.0, 123.5, 124.4 (d, J = 2.9 Hz), 124.7, 127.4, 128.2, 128.8 (d, J= 3.8 Hz), 128.9, 131.9, 132.3, 133.9, 136.4, 138.8, 140.2, 142.5, 144.5, 150.3.; 19F-NMR (CDCl3) δ: 37.2.
4'-(2-hydroxyethanesulfonyl)-4-methyl-3-(pyridin-2-ylethynyl)-1,1'-biphenyl (A8) 1H-NMR (CDCl3) δ: 8.66 (1H, dq, J= 5.0, 0.9 Hz), 8.00 (2H, dt, J = 8.5, 2.1 Hz), 7.85 (1H, d, J = 1.8 Hz), 7.79 (2H, dt, J = 8.7, 1.8 Hz), 7.72 (1H, td, J = 7.8, 1.8 Hz), 7.55 (2H, ddd, J = 13.5, 7.8, 1.6 Hz), 7.38 (1H, d, J = 7.8 Hz), 7.28 (1H, dt, J = 5.5, 1.9 Hz), 4.05 (2H, dd, J = 10.5, 6.4 Hz), 3.40 (2H, t, J = 5.3 Hz), 2.80 (1H, t, J = 6.4 Hz), 2.62 (3H, s).; 13C-NMR (CDCl3) δ: 20.5, 56.3, 58.4, 87.5, 93.0, 122.9, 123.0, 127.2, 127.7, 127.8, 128.6, 130.4, 131.1, 132.0, 132.1, 136.2, 136.4, 137.5, 141.4, 143.3, 145.9, 150.1.
4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl)ethynyl-1,1'-biphenyl (A9) 1H-NMR (CDCl3) δ: 8.46 (1H, d, J = 5.0 Hz), 8.01 (2H, d, J = 8.7 Hz), 7.84 (1H, s), 7.78 (2H, t, J = 4.1 Hz), 7.67-7.44 (6H, m), 7.19 (1H, dd, J = 7.6, 4.8 Hz), 4.05 (2H, s), 3.42 (2H, t, J = 5.7 Hz), 3.31 (1H, s), 2.55 (3H, s).; 13C-NMR (CDCl3) δ: 19.5, 56.3,58.4, 88.1, 92.3, 123.0, 123.5, 127.9, 128.0, 128.5, 128.6, 128.7, 129.3, 130.8, 132.0, 136.1, 137.2, 138.0, 139.3, 142.7, 145.9, 147.4.
4'-(2-hydroxyethanesulfonyl)-3-(6-methylpyridin-2-yl)ethynyl-4-methyl-1,1'-biphenyl (A10) 1H-NMR (CDCl3) δ: 7.96 (2H, d, J = 8.7 Hz), 7.82 (1H, s), 7.73 (2H, d, J= 8.7 Hz), 7.59 (1H, dd, J = 9.2, 6.0 Hz), 7.49 (1H, dd, J = 8.0, 1.6 Hz), 7.36 (2H, dd, J = 18.3, 7.8 Hz), 7.13 (1H, d, J = 7.3 Hz), 4.04 (2H, t, J = 5.7 Hz), 3.49 (1H, br s), 3.41 (2H, t, J = 5.7 Hz), 2.58 (6H, s).; 13C-NMR (CDCl3) δ: 20.4, 24.4, 56.1, 58.3, 87.1, 93.1, 122.8, 123.0, 124.4, 127.6, 128.5, 130.3, 131.0, 136.3, 136.4, 137.5, 141.2, 142.4, 145.6, 158.9.
4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl)ethynyl-4-methyl-1,1'-biphenyl (A11) 1H-NMR (CDCl3) δ: 8.49 (1H, dd, J = 4.8, 1.1 Hz), 8.00 (2H, dt, J = 8.7, 1.8 Hz), 7.87 (1H, d, J = 2.3 Hz), 7.80-7.77 (2H, m), 7.58 (1H, dt, J = 7.8, 0.9 Hz), 7.53 (1H, dd, J = 7.8, 1.8 Hz), 7.38 (1H, d, J= 7.8 Hz), 7.20 (1H, dd, J = 7.8, 4.6 Hz), 4.05 (2H, s), 3.42-3.39 (2H, m), 2.93 (1H, s), 2.62 (3H, s), 2.56 (3H, s).; 13C-NMR (CDCl3) δ: 19.7, 20.7, 56.4, 58.4, 91.2, 92.0, 122.9, 123.4, 127.7, 127.8, 128.6, 130.4, 131.3, 135.9, 136.5, 137.1, 137.5, 141.2, 143.0, 145.9, 147.5.
4'-(2-hydroxyethanesulfonyl)-2-methyl-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A12) 1H-NMR (CDCl3) δ: 8.61 (1H, dq, J= 5.0, 0.9 Hz), 7.99 (2H, dt, J = 8.4, 1.9 Hz), 7.69 (1H, td, J = 7.7, 1.7 Hz), 7.56-7.50 (4H, m), 7.47 (1H, d, J = 1.8 Hz), 7.31 (1H, d, J= 7.8 Hz), 7.25 (1H, tt, J = 6.4, 1.7 Hz), 4.07 (2H, q, J = 5.6 Hz), 3.44 (2H, td, J = 4.1, 2.1 Hz), 3.12 (1H, s), 2.27 (3H, s).; 13C-NMR (CDCl3) δ: 20.4, 56.3, 58.3, 88.7, 88.7, 120.1, 122.8, 127.1, 128.4, 130.2, 130.9, 131.7, 132.1, 132.9, 136.2, 136.4, 137.7, 139.9, 143.2, 146.9, 150.0.
4'-(2-hydroxyethanesulfonyl)-4-propyl-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A14) 1H-NMR (CDCl3) δ: 8.64 (1H, dq, J= 4.9, 0.9 Hz), 8.00-7.97 (2H, m), 7.85 (1H, d, J = 1.8 Hz), 7.79-7.77 (2H, m), 7.72 (1H, td, J = 7.8, 1.8 Hz), 7.54 (2H, dd, J = 7.8, 1.2 Hz), 7.36 (1H, d, J = 7.9 Hz), 7.28 (1H, ddd, J = 7.6, 5.0, 1.1 Hz), 4.05 (2H, dd, J = 11.0, 5.9 Hz), 3.43-3.40 (2H, m), 3.15 (1H, s), 2.92 (2H, t, J = 7.6 Hz), 1.79 (2H, td, J = 14.9, 7.4 Hz), 1.03 (3H, t, J = 7.4 Hz).; 13C-NMR (CDCl3) δ: 13.9, 23.7, 36.3, 56.3, 58.3, 87.5, 92.4, 122.6, 122.9, 127.2, 127.7, 128.6, 129.7, 131.5, 136.3, 136.4, 137.5, 143.3, 145.8, 145.8, 150.1.
4'-(2-hydroxyethanesulfonyl)-4-pentyl-3-(pyridin-2-ylethynyl)-1,1'-biphenyl (A16) 1H-NMR (CDCl3) δ: 8.65 (1H, d, J = 4.1 Hz), 7.99 (2H, d, J = 8.7 Hz), 7.86 (1H, d, J= 1.8 Hz), 7.79 (2H, d, J = 8.2 Hz), 7.71 (1H, td, J = 7.8, 1.8 Hz), 7.54 (2H, td, J = 5.3, 2.7 Hz), 7.37 (1H, d, J = 7.8 Hz), 7.27 (1H, ddd, J = 7.7, 4.9, 1.3 Hz), 4.05 (2H, dd, J = 11.0, 6.4 Hz), 3.40 (2H, dd, J = 7.1, 3.9 Hz), 2.94 (2H, t, J = 7.8 Hz), 2.89 (1H, t, J = 6.4 Hz), 1.75 (2H, dd, J = 15.1, 7.3 Hz), 1.43-1.38 (4H, m), 0.90 (3H, t, J = 7.1 Hz).; 13C-NMR (CDCl3) δ: 14.0, 22.5, 30.3, 31.6, 34.3, 56.4, 58.4, 87.5, 92.5, 122.6, 122.9, 127.2, 127.8, 127.8, 128.6, 129.7, 131.6, 136.2, 136.4, 137.5, 143.4, 145.9, 146.2, 150.2.
4'-(2-hydroxyethanesulfonyl)-4-iso-propyl-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A17) 1H-NMR (CDCl3) δ: 8.66 (1H, d, J= 5.0 Hz), 8.00 (2H, t, J = 4.4 Hz), 7.86 (1H, d, J = 1.8 Hz), 7.79 (2H, t, J = 4.4 Hz), 7.71 (1H, td, J = 7.8, 1.8 Hz), 7.59 (1H, dd, J = 8.0, 2.1 Hz), 7.56 (1H, d, J = 7.8 Hz), 7.44 (1H, d, J = 8.2 Hz), 7.27 (1H, tt, J = 5.7, 1.7 Hz), 4.05 (2H, q, J= 5.6 Hz), 3.64 (1H, t, J = 6.9 Hz), 3.41 (2H, td, J = 4.2, 2.1 Hz), 2.90 (1H, s), 1.36 (6H, d, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 23.1, 31.6, 56.4, 58.4, 87.4, 92.8, 122.0, 122.9, 126.1, 127.3, 127.8, 128.2, 128.6, 131.7, 136.2, 136.4, 137.5, 143.4, 146.0, 150.2, 151.7.
4-iso-butyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A18) 1H-NMR (CDCl3) δ: 8.64 (1H, d, J= 4.6 Hz), 7.99 (2H, d, J = 8.2 Hz), 7.87 (1H, d, J = 1.8 Hz), 7.79 (2H, d, J = 8.2 Hz), 7.71 (1H, td, J = 7.7, 1.7 Hz), 7.54 (2H, dt, J = 7.8, 2.1 Hz), 7.32 (1H, d, J = 8.2 Hz), 7.27 (1H, dd, J = 8.0, 4.4 Hz), 4.05 (2H, q, J = 5.5 Hz), 3.41 (2H, t, J= 5.5 Hz), 2.98 (1H, t, J = 6.2 Hz), 2.82 (2H, d, J = 6.9 Hz), 2.15-2.09 (1H, m), 1.01 (6H, d, J = 6.4 Hz).; 13C-NMR (CDCl3) δ: 22.5, 29.9, 43.6, 56.4, 58.4, 87.9, 92.6, 122.9, 123.0, 127.1, 127.5, 127.4, 128.6, 130.6, 131.5, 136.2, 136.5, 137.5, 143.4, 145.1, 145.9, 150.2.
4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl)ethynyl-4-propyl-1,1'-biphenyl (A19) 1H-NMR (CDCl3) δ: 8.48 (1H, dd, J = 4.7, 0.9 Hz), 7.99 (2H, dt, J = 8.7, 2.0 Hz), 7.89 (1H, d, J = 1.9 Hz), 7.79 (2H, dt, J = 8.7, 2.0 Hz), 7.56 (2H, ddt, J = 11.8, 7.2, 2.5 Hz), 7.37 (1H, d, J = 8.0 Hz), 7.19 (1H, dd, J = 7.8, 4.7 Hz), 4.05 (2H, dt, J = 5.9, 2.4 Hz), 3.42-3.40 (2H, m), 2.94 (3H, t, J = 7.7 Hz), 2.56 (3H, s), 1.79 (2H, td, J = 15.0, 7.5 Hz), 1.02 (3H, t, J = 7.3 Hz).; 13C-NMR (CDCl3) δ: 14.0, 19.6, 23.8, 36.5, 56.4, 58.4, 91.2, 91.4, 122.8, 122.9, 127.7, 127.8, 128.6, 129.7, 131.7, 135.8, 136.5, 137.1, 137.5, 143.0, 145.6, 145.9, 147.5.
4'-(2-hydroxyethanesulfonyl)-3-(3-penthylpyridin-2-yl)ethynyl-4-propyl-1,1'-biphenyl (A21) 1H-NMR (CDCl3) δ: 8.49 (1H, t, J = 2.4 Hz), 8.00 (2H, d, J = 8.3 Hz), 7.89 (1H, d, J = 1.7 Hz), 7.79 (2H, t, J = 4.1 Hz), 7.56 (2H, td, J = 8.0, 1.7 Hz), 7.37 (1H, d, J = 8.0 Hz), 7.21 (1H, dd, J= 7.8, 4.7 Hz), 4.05 (2H, dd, J = 10.8, 6.3 Hz), 3.41 (2H, td, J= 4.2, 2.1 Hz), 2.92 (5H, dt, J = 19.2, 7.7 Hz), 1.77 (4H, tt, J= 21.5, 7.1 Hz), 1.40-1.36 (4H, m), 1.02 (3H, t, J = 7.3 Hz), 0.89 (3H, t, J = 7.0 Hz).; 13C-NMR (CDCl3) δ: 13.9, 14.0, 22.6, 23.8, 30.0, 31.6, 33.3, 36.3, 56.4, 58.4, 90.4, 91.5, 122.9, 123.1, 127.7, 127.8, 128.6, 129.7, 131.8, 136.4, 136.5, 137.5, 140.4, 142.6, 145.5, 146.0, 147.6.
4-heptyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A22) 1H-NMR (CDCl3) δ: 8.66-8.64 (1H, m), 7.99 (2H, dd, J = 6.4, 1.8 Hz), 7.86 (1H, d, J = 1.8 Hz), 7.79 (2H, dt, J = 8.7, 1.8 Hz), 7.72 (1H, td, J = 7.8, 1.8 Hz), 7.54 (2H, dt, J = 7.9, 1.7 Hz), 7.36 (1H, d, J = 7.8 Hz), 7.28 (1H, tt, J = 5.7, 1.8 Hz), 4.05 (2H, q, J = 5.6 Hz), 3.42-3.40 (2H, m), 2.99-2.92 (3H, m), 1.78-1.71 (2H, m), 1.38 (4H, tt, J = 18.8, 5.2 Hz), 1.28 (4H, dt, J = 11.3, 4.4 Hz), 0.86 (3H, t, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 14.1, 22.6, 29.1, 29.4, 30.6, 31.8, 34.4, 56.4, 58.3, 87.5, 92.5, 122.6, 122.9, 127.2, 127.8, 127.9, 128.6, 129.7, 131.5, 136.2, 136.4, 137.4, 143.3, 145.9, 146.2, 150.1.
4'-(2-hydroxyethanesulfonyl)-4-octyl-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A23) 1H-NMR (CDCl3) δ: 8.65 (1H, d, J= 5.0 Hz), 8.00 (2H, d, J = 8.7 Hz), 7.86 (1H, d, J = 1.8 Hz), 7.79 (2H, d, J = 8.2 Hz), 7.71 (1H, td, J = 7.8, 1.8 Hz), 7.56-7.53 (2H, m), 7.37 (1H, d, J = 7.8 Hz), 7.29-7.27 (2H, m), 4.05 (2H, q, J = 5.6 Hz), 3.41 (2H, t, J = 5.3 Hz), 2.96-2.90 (3H, m), 1.78-1.70 (2H, m), 1.35 (10H, dq, J = 44.9, 10.4 Hz), 0.86 (3H, t, J= 6.9 Hz).; 13C-NMR (CDCl3) δ: 14.1, 22.6, 29.3, 29.4, 30.6, 31.9, 34.4, 56.4, 58.3, 87.5, 92.5, 122.6, 122.9, 127.2, 127.8, 127.8, 128.6, 129.7, 131.5, 136.2, 136.4, 137.4, 143.4, 145.9, 146.2, 150.2.
4-cyclo-hexyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A24) 1H-NMR (CDCl3) δ: 8.62 (1H, dd, J= 5.0, 0.9 Hz), 7.99 (2H, t, J = 4.4 Hz), 7.93 (1H, d, J = 16.0 Hz), 7.89 (1H, d, J = 1.8 Hz), 7.81 (2H, dd, J = 8.7, 1.8 Hz), 7.69 (1H, td, J = 7.6, 1.8 Hz), 7.46 (2H, td, J = 10.1, 4.0 Hz), 7.31 (1H, d, J = 7.8 Hz), 7.20-7.14 (2H, m), 4.04 (2H, d, J = 3.7 Hz), 3.40 (2H, td, J = 6.5, 4.1 Hz), 3.27 (1H, s), 2.84 (2H, t, J= 7.8 Hz), 1.69-1.61 (2H, m), 1.44-1.26 (10H, m), 0.86 (3H, t, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 26.1, 26.9, 33.4, 42.1, 56.3, 58.3, 87.5, 92.7, 122.1, 122.9, 126.5, 127.2, 127.7, 128.1, 128.6, 131.6, 136.2, 136.3, 137.4, 143.3, 145.8, 150.1, 150.7.
4'-(2-hydroxyethanesulfonyl)-4-cyclo-pentyl-5-(pyridin-2-ylethynyl)-1,1'-biphenyl (A25) 1H-NMR (CDCl3) δ: 8.65 (1H, d, J= 5.0 Hz), 7.99 (2H, d, J = 8.2 Hz), 7.85 (1H, d, J = 1.8 Hz), 7.78 (2H, d, J = 8.7 Hz), 7.72 (1H, td, J = 7.8, 1.8 Hz), 7.58-7.54 (2H, m), 7.44 (1H, d, J = 8.2 Hz), 7.28 (1H, dt, J = 6.4, 2.6 Hz), 4.05 (2H, d, J = 5.0 Hz), 3.67 (1H, t, J = 8.2 Hz), 3.41 (2H, t, J = 5.5 Hz), 3.05 (1H, s), 2.20 (2H, s), 1.87-1.70 (6H, m).; 13C-NMR (CDCl3) δ: 25.8, 34.0, 43.5, 56.3, 58.3, 87.8, 92.7, 122.5, 122.9, 126.6, 127.2, 127.7, 128.0, 128.6, 131.7, 136.2, 136.3, 137.4, 143.4, 145.8, 149.7, 150.1.
(2)B1〜B25の合成
B1〜B25の合成は下記合成法により合成した。
合成したB1〜B25のNMRを下記に示す。
4'-(2-hydroxyethanesulfonyl)-3-(pyridin-2-ylethyl)-1,1'-biphenyl (B1) 1H-NMR (CDCl3) δ: 8.55 (1H, t, J= 2.5 Hz), 7.97 (2H, t, J = 4.1 Hz), 7.71 (2H, t, J = 4.1 Hz), 7.59 (1H, td, J = 7.7, 1.8 Hz), 7.39 (3H, m), 7.27 (1H, dd, J = 7.5, 1.1 Hz), 7.15-7.10 (2H, m), 4.04 (2H, s), 3.65 (1H, s), 3.41 (2H, dd, J= 8.2, 3.2 Hz), 3.13 (4H, s).; 13C-NMR (CDCl3) δ: 35.9, 40.0, 56.1, 58.3, 121.3, 123.1, 125.0, 127.5, 127.9, 128.2, 128.4, 128.8, 129.1, 136.5, 137.3, 138.9, 142.3, 146.9, 149.1, 160.7.
2-fluoro-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B2) 1H-NMR (CDCl3) δ: 8.55 (1H, dq, J= 5.0, 0.9 Hz), 7.98 (2H, dt, J = 8.5, 2.1 Hz), 7.71-7.46 (4H, m), 7.21 (2H, dt, J = 8.1, 3.2 Hz), 7.15 (1H, ddd, J = 7.6, 5.0, 1.1 Hz), 7.08 (2H, ddd, J = 9.8, 7.3, 1.6 Hz), 4.05 (2H, t, J = 5.7 Hz), 3.51 (1H, s), 3.43-3.40 (2H, m), 3.10 (4H, q, J = 4.4 Hz).; 13C-NMR (CDCl3) δ: 35.0, 40.0, 56.2, 58.3, 116.2 (d, J = 23.0 Hz), 121.4, 123.1, 126.5 (d, J = 13.4 Hz), 128.0, 128.5 (d, J = 11.5 Hz), 129.9 (d, J = 2.9 Hz), 130.4 (t, J = 8.1 Hz), 132.0 (t, J = 5.3 Hz), 136.5, 137.8, 137.9 (d, J= 3.8 Hz), 141.8 (d, J = 1.9 Hz), 149.2, 156.8, 159.3, 160.5.
4'-(2-hydroxyethanesulfonyl)-3-(6-methylpyridin-2-yl)-ethyl-1,1'-biphenyl (B3) 1H-NMR (CDCl3) δ: 7.97 (2H, t, J = 4.4 Hz), 7.73 (2H, t, J = 4.4 Hz), 7.48 (1H, t, J = 7.6 Hz), 7.40 (3H, dq, J = 13.3, 4.3 Hz), 7.28 (1H, t, J = 3.7 Hz), 7.00 (1H, d, J = 7.3 Hz), 6.91 (1H, d, J= 7.8 Hz), 4.04 (2H, t, J = 5.7 Hz), 3.51 (1H, br s), 3.41 (2H, t, J= 5.5 Hz), 3.10 (4H, s), 2.55 (3H, s).; 13C-NMR (CDCl3) δ: 24.4, 36.2, 40.0, 56.1, 58.3, 119.9, 120.8, 125.0, 127.6, 127.9, 128.4, 129.0, 129.0, 136.7, 137.3, 138.9, 142.5, 147.0, 157.8, 160.1.
2-fluoro-4'-(2-hydroxyethanesulfonyl)-5-(6-methylpyridin-2-yl)ethyl-1,1'-biphenyl (B4) 1H-NMR (CDCl3) δ: 7.98-7.95 (2H, m), 7.69 (2H, dd, J = 8.5, 1.6 Hz), 7.48 (1H, t, J = 7.8 Hz), 7.22 (2H, ddd, J = 12.0, 6.3, 2.6 Hz), 7.08 (1H, dd, J = 10.5, 8.2 Hz), 7.00 (1H, d, J = 7.8 Hz), 6.90 (1H, d, J = 7.8 Hz), 4.04 (2H, t, J = 5.7 Hz), 3.60 (1H, br s), 3.42 (2H, dd, J = 6.9, 4.6 Hz), 3.06 (4H, s), 2.54 (3H, s).; 13C-NMR (CDCl3) δ: 24.2, 35.2, 39.9, 56.0, 28.2, 116.1 (d, J = 23.0 Hz), 119.9, 120.9, 126.4 (d, J = 13.4 Hz), 127.9, 128.5 (d, J = 12.5 Hz), 129.8 (d, J = 2.9 Hz), 130.3 d, J = 7.7 Hz), 130.4 (d, J = 2.9 Hz), 132.0 (d, J = 3.8 Hz), 136.7, 137.8, 137.9 (d, J = 3.8 Hz), 141.7, 156.7, 157.8, 159.2, 159.8.; 19F-NMR (CDCl3) δ: 31.8.
3-tert-butyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B5) 1H-NMR (CDCl3) δ: 8.58 (1H, dt, J= 4.0, 1.4 Hz), 7.99-7.96 (2H, m), 7.76-7.73 (2H, m), 7.62 (2H, ddt, J = 24.7, 11.4, 4.0 Hz), 7.45 (1H, ddd, J = 14.4, 7.1, 4.1 Hz), 7.26 (2H, t, J = 2.1 Hz), 7.16-7.09 (2H, m), 4.04 (2H, t, J = 5.3 Hz), 3.42-3.39 (2H, m), 3.23 (1H, s), 3.13 (4H, s), 1.34 (9H, s).; 13C-NMR (CDCl3) δ: 31.3, 34.8, 36.8, 40.3, 56.3, 58.4, 121.3, 122.2, 123.1, 124.8,126.3, 128.1, 128.4, 128.6, 132.0, 136.4, 137.1, 138.8, 142.1, 147.7, 149.3, 152.1, 161.0.
4'-(2-hydroxyethanesulfonyl)-3-methyl-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B6) 1H-NMR (CDCl3) δ: 8.56 (1H, d, J= 3.7 Hz), 7.97-7.94 (2H, m), 7.71 (2H, dd, J = 6.4, 1.8 Hz), 7.59 (1H, td, J = 7.8, 1.8 Hz), 7.22 (2H, d, J = 11.9 Hz), 7.13 (3H, td, J= 6.5, 4.4 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.49 (1H, s), 3.40 (2H, dd, J= 6.9, 4.6 Hz), 3.10 (4H, ddd, J = 14.7, 8.2, 4.6 Hz), 2.39 (3H, s).; 13C-NMR (CDCl3) δ: 21.4, 35.9, 40.1, 56.2, 58.3, 121.3, 123.0, 124.7, 125.8, 127.9, 128.3, 129.7, 136.4, 137.2, 138.8, 138.9, 142.3, 147.1, 149.2, 160.9.
4'-(2-hydroxyethanesulfonyl)-3-(pyridin-2-ylethyl)-5-trifluoromethyl-1,1'-biphenyl (B7) 1H-NMR (CDCl3) δ: 8.59 (1H, dt, J= 4.3, 1.5 Hz), 8.02 (2H, dt, J = 8.5, 2.1 Hz), 7.74 (2H, dt, J = 8.7, 1.8 Hz), 7.66 (1H, s), 7.62-7.58 (2H, m), 7.51 (1H, s), 7.16 (1H, ddd, J= 7.4, 4.9, 1.0 Hz), 7.10 (1H, d, J = 7.8 Hz), 4.06 (2H, t, J = 5.0 Hz), 3.41 (2H, td, J = 4.1, 2.0 Hz), 3.23 (2H, dt, J = 9.5, 3.9 Hz), 3.18-3.13 (2H, m), 2.86 (1H, s).; 13C-NMR (CDCl3) δ: 35.6, 39.7, 56.2, 58.4, 121.5, 121.9 (q, J = 3.8 Hz), 123.1, 125.2, 125.5 (q, J = 3.5 Hz), 128.1, 128.5 (t, J = 9.6 Hz), 128.6 (d, J = 6.7 Hz), 130.9 (d, J = 1.9 Hz), 131.4, 131.9, 132.0 (t, J = 2.9 Hz), 132.7, 136.5, 138.3, 139.8, 143.5, 145.5, 149.4, 160.1.; 19F-NMR (CDCl3) δ: 37.6.
4'-(2-hydroxyethanesulfonyl)-4-methyl-3-(pyridin-2-ylethyl)-1,1'-biphenyl (B8) 1H-NMR (CDCl3) δ: 8.59-8.57 (1H, m), 7.95 (2H, dt, J = 8.7, 1.8 Hz), 7.70 (2H, dt, J = 8.7, 1.8 Hz), 7.59 (1H, td, J = 7.6, 1.8 Hz), 7.37-7.35 (2H, m), 7.27 (1H, s), 7.15 (1H, ddd, J = 7.6, 4.8, 1.1 Hz), 7.10 (1H, d, J = 7.8 Hz), 4.03 (2H, s), 3.41-3.38 (2H, m), 3.26 (1H, s), 3.12-3.09 (4H, m), 2.38 (3H, s).; 13C-NMR (CDCl3) δ: 19.0, 33.4, 38.8, 56.3, 58.4, 121.3, 123.0, 125.0, 127.7, 127.9, 128.4, 131.0, 136.4, 136.5, 137.0, 137.0, 140.1, 147.0, 149.3, 161.0.
4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl)ethyl-1,1'-biphenyl (B9) 1H-NMR (CDCl3) δ: 8.41 (1H, dd, J = 4.8, 1.6 Hz), 7.97 (2H, dt, J = 8.4, 1.9 Hz), 7.72 (2H, dt, J = 8.4, 1.9 Hz), 7.41 (4H, ddd, J = 14.0, 8.9, 3.2 Hz), 7.30 (1H, dt, J = 7.0, 1.6 Hz), 7.08 (1H, dd, J= 7.6, 4.8 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.46 (1H, s), 3.42-3.39 (2H, m), 3.11 (4H, s), 2.23 (3H, s).; 13C-NMR (CDCl3) δ: 18.7, 34.9, 37.1, 56.2, 58.4, 121.4, 125.0, 127.6, 128.0, 128.4, 128.6, 128.9, 129.1, 131.2, 131.9, 137.4, 137.7, 139.0, 142.8, 146.7, 147.0, 159.0.
4'-(2-hydroxyethanesulfonyl)-3-(6-methylpyridin-2-yl)ethyl-4-methyl-1,1'-biphenyl (B10) 1H-NMR (CDCl3) δ: 7.95 (2H, dt, J = 8.7, 1.8 Hz), 7.72-7.69 (2H, m), 7.47 (1H, t, J = 7.8 Hz), 7.36 (2H, dt, J = 9.8, 3.4 Hz), 7.25 (1H, t, J = 5.3 Hz), 7.00 (1H, d, J = 7.3 Hz), 6.89 (1H, d, J = 7.8 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.41-3.38 (2H, m), 3.23 (1H, s), 3.08 (4H, dt, J = 12.7, 4.9 Hz), 2.56 (3H, s), 2.37 (3H, s).; 13C-NMR (CDCl3) δ: 19.0, 24.5, 33.5, 38.7, 56.3, 58.4, 119.8, 120.8, 124.9, 127.7, 127.9, 128.4, 130.9, 136.4, 136.6, 136.9, 137.0, 140.6, 147.0, 157.9, 160.4.
4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl)ethyl-4-methyl-1,1'-biphenyl (B11) 1H-NMR (CDCl3) δ: 8.44 (1H, dd, J = 5.0, 1.4 Hz), 7.97-7.93 (2H, m), 7.71-7.69 (2H, m), 7.67-7.63 (1H, m), 7.49-7.44 (1H, m), 7.35 (1H, dd, J= 5.0, 1.8 Hz), 7.27 (1H, t, J = 3.9 Hz), 7.08 (1H, dd, J = 7.6, 4.8 Hz), 4.03 (2H, t, J = 5.5 Hz), 3.41-3.38 (2H, m), 3.22 (1H, br s), 3.14-3.05 (4H, m), 2.41 (3H, s), 2.21 (3H, s).; 13C-NMR (CDCl3) δ: 18.7, 19.0, 32.4, 35.8, 56.3, 58.4, 121.4, 125.0, 127.7, 128.1, 128.4, 128.6, 131.0, 131.2, 132.0, 132.1, 136.6, 137.0, 137.7, 140.9, 146.8, 147.0, 159.2.
4'-(2-hydroxyethanesulfonyl)-2-methyl-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B12) 1H-NMR (CDCl3) δ: 8.54 (1H, dq, J= 4.9, 0.9 Hz), 7.96 (2H, dt, J = 8.6, 1.9 Hz), 7.59 (1H, td, J = 7.7, 1.8 Hz), 7.49 (2H, dt, J = 8.5, 1.9 Hz), 7.22-7.10 (4H, m), 7.02 (1H, d, J = 1.8 Hz), 4.06 (2H, dd, J = 7.0, 4.2 Hz), 3.54 (1H, br s), 3.43 (2H, dt, J = 5.8, 2.7 Hz), 3.13-3.03 (4H, m), 2.22 (3H, s).; 13C-NMR (CDCl3) δ: 19.8, 35.4, 40.0, 56.2, 58.3, 121.2, 123.0, 127.7, 128.3, 129.6, 130.1, 130.7, 132.5, 136.4, 137.1, 139.2, 139.6, 148.1, 149.1, 160.9.
4'-(2-hydroxyethanesulfonyl)-4-propyl-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B14) 1H-NMR (CDCl3) δ: 8.58 (1H, dq, J= 4.9, 0.9 Hz), 7.95 (2H, dt, J = 8.6, 1.9 Hz), 7.70 (2H, dt, J = 8.6, 2.0 Hz), 7.60 (1H, td, J = 7.6, 1.9 Hz), 7.39 (2H, t, J = 4.8 Hz), 7.27 (1H, t, J = 3.9 Hz), 7.16 (1H, ddd, J = 7.6, 4.9, 1.1 Hz), 7.10 (1H, d, J = 7.6 Hz), 4.04 (2H, t, J = 5.4 Hz), 3.44 (1H, s), 3.41-3.39 (2H, m), 3.16-3.07 (4H, m), 2.66 (2H, dd, J = 8.8, 6.9 Hz), 1.66 (2H, td, J = 15.1, 7.5 Hz), 1.01 (3H, t, J = 7.3 Hz).; 13C-NMR (CDCl3) δ: 14.1, 24.2, 32.8, 34.3, 39.7, 56.2, 58.3, 121.3, 123.0, 124.9, 127.6, 128.2, 128.4, 128.6, 130.0, 132.0, 136.3, 136.4, 136.9, 140.0, 141.4, 146.9, 149.3, 160.9.
4-ethoxy-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B15) 1H-NMR (CDCl3) δ: 8.55 (1H, dq, J= 4.9, 0.9 Hz), 7.92 (2H, t, J = 4.3 Hz), 7.66 (2H, dd, J = 6.8, 1.8 Hz), 7.57 (1H, td, J = 7.6, 1.9 Hz), 7.42 (1H, dd, J = 8.6, 2.5 Hz), 7.34 (1H, d, J = 2.5 Hz), 7.14-7.09 (2H, m), 6.92 (1H, d, J= 8.6 Hz), 4.10 (2H, q, J = 7.0 Hz), 4.02 (2H, t, J = 5.5 Hz), 3.33 (3H, dd, J = 27.1, 21.7 Hz), 3.11 (4H, s), 1.46 (3H, t, J = 7.0 Hz).; 13C-NMR (CDCl3) δ: 14.8, 30.8, 38.3, 56.3, 58.4, 63.6, 111.5, 121.1, 123.0, 126.2, 127.2, 128.4, 129.0, 130.5, 130.7, 136.3, 146.8, 149.1, 157.6, 161.6.
4'-(2-hydroxyethanesulfonyl)-4-pentyl-3-(pyridin-2-ylethyl)-1,1'-biphenyl (B16) 1H-NMR (CDCl3) δ: 8.58 (1H, t, J= 2.5 Hz), 7.95 (2H, t, J = 4.1 Hz), 7.70 (2H, t, J = 4.4 Hz), 7.59 (1H, td, J = 7.6, 1.8 Hz), 7.39 (2H, t, J = 4.8 Hz), 7.27 (1H, t, J = 3.7 Hz), 7.15 (1H, td, J = 6.2, 1.1 Hz), 7.09 (1H, d, J = 7.8 Hz), 4.04 (2H, s), 3.40 (2H, dd, J = 6.9, 4.1 Hz), 3.29 (1H, s), 3.12 (4H, ddd, J = 14.4, 8.0, 4.4 Hz), 2.67 (2H, t, J = 7.8 Hz), 1.61 (2H, dd, J = 15.6, 7.3 Hz), 1.38 (4H, dd, J = 7.1, 3.4 Hz), 0.91 (3H, t, J = 7.1 Hz).; 13C-NMR (CDCl3) δ: 14.0, 22.5, 30.8, 31.8, 32.3, 32.8, 39.7, 56.3, 58.4, 121.3, 123.0, 125.0, 127.7, 128.3, 130.0, 136.3, 136.4, 136.9, 140.0, 141.7, 147.0, 149.3, 161.0.
4'-(2-hydroxyethanesulfonyl)-4-iso-propyl-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B17) 1H-NMR (CDCl3) δ:8.59 (1H, dd, J = 5.0, 0.9 Hz), 7.95 (2H, dd, J = 6.6, 2.1 Hz), 7.72 (2H, dd, J = 6.4, 1.8 Hz), 7.59 (1H, td, J = 7.6, 2.0 Hz), 7.45 (1H, dd, J = 8.0, 2.1 Hz), 7.39 (2H, t, J = 5.3 Hz), 7.15 (1H, td, J = 6.2, 1.1 Hz), 7.09 (1H, d, J = 7.8 Hz), 4.04 (2H, s), 3.40 (2H, dd, J = 7.1, 3.9 Hz), 3.27 (1H, dd, J = 13.7, 6.9 Hz), 3.19-3.07 (5H, m), 1.27 (6H, d, J = 6.4 Hz).; 13C-NMR (CDCl3) δ: 24.0, 28.6, 32.9, 40.2, 56.3, 58.4, 121.3, 123.0, 125.4, 126.2, 127.7, 128.4, 128.5, 136.1, 136.4, 137.0, 139.2, 147.0, 147.7, 149.4, 161.0.
4-iso-butyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B18) 1H-NMR (CDCl3) δ:8.58 (1H, d, J = 4.1 Hz), 7.96-7.94 (2H, m), 7.71 (2H, dt, J = 8.7, 1.8 Hz), 7.59 (1H, td, J = 7.8, 1.8 Hz), 7.38 (2H, dd, J = 6.0, 2.3 Hz), 7.23 (1H, t, J = 4.4 Hz), 7.15 (1H, dt, J = 5.8, 2.7 Hz), 7.08 (1H, d, J = 7.8 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.41-3.38 (2H, m), 3.18 (1H, s), 3.11 (4H, tt, J = 11.7, 4.3 Hz), 2.56 (2H, d, J = 7.3 Hz), 1.94-1.87 (1H, m), 0.96 (6H, d, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 22.6, 29.8, 32.8, 39.8, 41.5, 56.3, 58.4, 121.3, 123.0, 124.7, 127.7, 128.3, 128.4, 130.9, 136.3, 136.4, 136.9, 140.4, 140.5, 147.0, 149.4, 161.0.
4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl)ethyl-4-propyl-1,1'-biphenyl (B19) 1H-NMR (CDCl3) δ:8.44 (1H, dd, J = 5.0, 1.2 Hz), 7.95 (2H, dt, J = 8.6, 2.0 Hz), 7.70 (2H, dt, J = 8.7, 2.0 Hz), 7.44-7.37 (3H, m), 7.28 (1H, t, J= 4.0 Hz), 7.08 (1H, dd, J = 7.6, 4.7 Hz), 4.04 (2H, t, J = 5.6 Hz), 3.40 (2H, dt, J = 5.8, 2.5 Hz), 3.35 (1H, br s), 3.15-3.05 (4H, m), 2.69 (2H, dd, J = 8.9, 6.7 Hz), 2.21 (3H, s), 1.72-1.63 (2H, m), 1.02 (3H, t, J = 7.3 Hz).; 13C-NMR (CDCl3) δ: 14.2, 18.7, 24.3, 31.8, 34.4, 36.8 56.3, 58.4, 121.4, 125.0, 127.7, 128.4, 128.4, 128.4, 130.0, 131.2, 132.0, 136.4, 137.0, 137.7, 140.4, 141.4, 146.8, 146.9, 159.3.
4'-(2-hydroxyethanesulfonyl)-3-(3-penthylpyridin-2-yl)ethyl-4-propyl-1,1'-biphenyl (B21) 1H-NMR (CDCl3) δ:8.45 (1H, dd, J = 4.8, 1.7 Hz), 7.97-7.94 (2H, m), 7.70 (2H, dt, J= 8.6, 2.0 Hz), 7.45-7.38 (3H, m), 7.28 (1H, t, J = 5.0 Hz), 7.11 (1H, dd, J = 7.6, 4.8 Hz), 4.06-4.03 (2H, m), 3.41-3.38 (2H, m), 3.31 (1H, br s), 3.12 (4H, ddt, J = 19.2, 9.7, 3.6 Hz), 2.69 (2H, dd, J = 8.9, 7.0 Hz), 2.51 (2H, t, J = 7.9 Hz), 1.72-1.63 (2H, m), 1.54-1.46 (2H, m), 1.29 (4H, tt, J = 9.6, 3.6 Hz), 1.02 (3H, dd, J = 9.3, 5.2 Hz), 0.87 (3H, tt, J = 7.1, 2.3 Hz).; 13C-NMR (CDCl3) δ: 13.9, 14.2, 22.4, 24.3, 30.2, 31.7, 32.0,32.5, 34.4, 36.2, 56.3, 58.4, 121.4, 125.0, 127.7, 127.9, 128.4, 128.4, 129.4, 130.0, 135.8, 136.4, 136.8, 137.0, 140.5, 141.4, 146.7, 146.9, 158.8.
4-heptyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B22) 1H-NMR (CDCl3) δ:8.57 (1H, t, J = 2.5 Hz), 7.95 (2H, d, J = 8.2 Hz), 7.70 (2H, t, J= 4.4 Hz), 7.59 (1H, td, J = 7.8, 1.8 Hz), 7.38 (2H, t, J = 4.4 Hz), 7.27 (2H, t, J = 4.1 Hz), 7.17-7.14 (1H, m), 7.09 (1H, d, J= 7.8 Hz), 4.04 (2H, t, J = 5.7 Hz), 3.63 (1H, s), 3.40 (2H, dd, J= 7.1, 4.4 Hz), 3.16-3.07 (4H, m), 2.67 (2H, t, J = 8.0 Hz), 1.65-1.58 (2H, m), 1.44-1.28 (8H, m), 0.88 (3H, t, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 14.0, 22.6, 29.1, 29.6, 31.7, 32.3, 32.8, 39.6, 56.1, 58.3, 121.3, 123.0, 124.9, 127.6, 128.2, 128.3, 129.9, 136.2, 136.5, 137.0, 139.9, 141.6, 146.8, 149.2, 160.9.
4'-(2-hydroxyethanesulfonyl)-4-octyl-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B23) 1H-NMR (CDCl3) δ:8.58 (1H, t, J = 2.5 Hz), 7.96-7.93 (2H, m), 7.73-7.69 (2H, m), 7.59 (1H, td, J = 7.6, 1.8 Hz), 7.39 (2H, t, J = 4.8 Hz), 7.27 (1H, t, J = 3.9 Hz), 7.17-7.14 (1H, m), 7.09 (1H, d, J = 7.8 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.41-3.38 (3H, m), 3.16-3.07 (4H, m), 2.67 (2H, t, J= 8.0 Hz), 1.65-1.58 (2H, m), 1.35 (10H, dq, J = 33.8, 8.3 Hz), 0.88 (3H, t, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 14.1, 22.6, 29.2, 29.4, 29.7, 31.1, 31.8, 32.3, 32.8, 39.7, 56.2, 58.3, 121.3, 123.0, 125.0, 127.6, 128.2, 128.4, 130.0, 136.3, 136.4, 136.9, 140.0, 141.7, 146.9, 149.3, 161.0.
4-cyclo-hexyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B24) 1H-NMR (CDCl3) δ:8.58 (1H, d, J = 5.0 Hz), 7.94 (2H, d, J = 8.2 Hz), 7.70 (2H, d, J= 8.2 Hz), 7.58 (1H, td, J = 7.6, 1.8 Hz), 7.42 (1H, dd, J = 8.0, 2.1 Hz), 7.35 (2H, dd, J = 6.9, 5.0 Hz), 7.16-7.13 (1H, m), 7.05 (1H, d, J = 7.8 Hz), 4.03 (2H, t, J = 5.5 Hz), 3.58 (1H, s), 3.40 (2H, dd, J = 7.3, 4.1 Hz), 3.19-3.14 (2H, m), 3.10-3.06 (2H, m), 2.77 (1H, t, J = 9.8 Hz), 1.79 (5H, dt, J = 38.8, 12.7 Hz), 1.38 (5H, dtd, J= 65.2, 19.6, 9.5 Hz).; 13C-NMR (CDCl3) δ: 26.1, 26.9, 32.8, 34.3, 39.4, 40.1, 56.2, 58.3, 121.3, 123.1, 125.2, 126.8, 127.6, 128.3, 128.4, 131.9, 132.0, 135.9, 136.4, 136.9, 139.1, 146.6, 146.8, 149.2, 160.9.
4'-(2-hydroxyethanesulfonyl)-4-cyclo-pentyl-5-(pyridin-2-ylethyl)-1,1'-biphenyl (B25) 1H-NMR (CDCl3) δ:8.59 (1H, dq, J = 5.0, 0.9 Hz), 7.95 (2H, dt, J = 8.7, 1.8 Hz), 7.71 (2H, dt, J = 8.7, 1.8 Hz), 7.59 (1H, td, J = 7.8, 1.8 Hz), 7.44 (1H, dd, J = 8.2, 1.8 Hz), 7.39 (1H, d, J = 7.8 Hz), 7.36 (1H, d, J = 2.3 Hz), 7.15 (1H, ddd, J = 7.6, 5.0, 1.1 Hz), 7.08 (1H, dd, J = 7.8, 0.9 Hz), 4.04 (2H, t, J = 5.3 Hz), 3.40 (2H, td, J = 4.1, 2.1 Hz), 3.34-3.16 (4H, m), 3.13-3.06 (2H, m), 2.09-2.02 (2H, m), 1.86 (2H, ddt, J = 23.1, 13.3, 4.6 Hz), 1.80-1.69 (2H, m), 1.62 (2H, dtd, J = 20.1, 7.8, 3.7 Hz).; 13C-NMR (CDCl3) δ: 25.9, 33.2, 35.1, 40.2, 40.7, 56.3, 58.3, 121.3, 123.1, 125.4, 126.9, 127.7, 128.3, 128.4, 135.9, 136.4, 136.9, 140.0, 145.6, 146.9, 149.3, 161.0.
(3)C1〜C25の合成
C1〜C25の合成は下記合成法により合成した。
合成したC1〜C25のNMRを下記に示す。
(E)-4'-(2-hydroxyethanesulfonyl)-3-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C1) 1H-NMR (CDCl3) δ: 8.60 (1H, dd, J= 4.8, 1.0 Hz), 7.99 (2H, dt, J = 8.8, 1.9 Hz), 7.79-7.76 (3H, m), 7.70-7.61 (3H, m), 7.54-7.41 (3H, m), 7.25 (1H, d, J = 21.0 Hz), 7.17 (1H, ddd, J = 7.5, 4.9, 1.0 Hz), 4.06-4.03 (2H, m), 3.43-3.40 (3H, m).; 13C-NMR (CDCl3) δ: 56.2, 58.3, 122.2, 122.3, 126.0, 127.2, 128.0, 128.5, 128.7, 129.4, 132.0, 136.7, 137.4, 137.7, 139.4, 146.6, 149.6, 155.1.
(E)-2-fluoro-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C2) 1H-NMR (CDCl3) δ: 8.60 (1H, dd, J= 5.0, 0.9 Hz), 8.01 (2H, dt, J = 8.7, 1.8 Hz), 7.77 (2H, dd, J = 8.2, 1.4 Hz), 7.71-7.44 (5H, m), 7.39 (1H, d, J = 7.8 Hz), 7.22-7.13 (3H, m), 4.05 (2H, t, J = 5.5 Hz), 3.44-3.38 (3H, m).; 13C-NMR (CDCl3) δ: 56.2, 58.3, 116.8 (d, J = 23.0 Hz), 122.3 (d, J = 12.5 Hz), 127.2 (d, J = 12.5 Hz), 128.4, 128.5 (dd, J = 10.1, 7.2 Hz), 128.3, 129.9 (d, J= 2.9 Hz), 130.8, 132.0 (d, J = 5.3 Hz), 132.1 (t, J = 104.5 Hz), 133.5 (d, J = 3.8 Hz), 136.7, 138.1, 141.4, 141.4, 149.6, 155.0, 158.2, 160.7.
(E)-4'-(2-hydroxyethanesulfonyl)-3-(6-methylpyridin-2-yl-2-vinyl)-1,1'-biphenyl (C3) 1H-NMR (CDCl3) δ: 8.00 (2H, dd, J = 6.6, 2.1 Hz), 7.80 (3H, td, J = 4.2, 2.3 Hz), 7.66-7.56 (3H, m), 7.50 (2H, dt, J = 8.4, 4.1 Hz), 7.28-7.23 (2H, m), 7.05 (1H, d, J = 7.8 Hz), 4.05 (2H, t, J = 5.5 Hz), 3.43-3.40 (2H, m), 2.59 (3H, s).; 13C-NMR (CDCl3) δ: 24.6, 56.3, 58.3, 118.9, 122.0, 126.0, 127.0, 127.2, 128.0, 128.5, 129.2, 129.4, 131.6, 136.8, 137.5, 137.6, 139.3, 146.7, 154.6, 158.3.
(E)-2-fluoro-4'-(2-hydroxyethanesulfonyl)-5-(6-methylpyridin-2-yl-2-vinyl)-1,1'-biphenyl (C4) 1H-NMR (CDCl3) δ: 8.01 (2H, dt, J = 8.9, 1.9 Hz), 7.78 (2H, dd, J = 8.5, 1.6 Hz), 7.64 (1H, dd, J = 7.3, 2.3 Hz), 7.58 (3H, tt, J = 10.1, 3.3 Hz), 7.20 (3H, tt, J = 16.7, 8.2 Hz), 7.04 (1H, d, J = 7.8 Hz), 4.05 (2H, dd, J = 6.9, 4.1 Hz), 3.43-3.41 (2H, m), 2.99 (1H, s), 2.58 (3H, s).; 13C-NMR (CDCl3) δ: 24.5, 56.2, 58.3, 116.8 (d, J = 23.0 Hz), 118.9, 122.0, 127.0, 128.1, 128.8 (t, J = 1.9 Hz), 129.1 (d, J = 3.8 Hz), 129.9 (d, J = 2.9 Hz), 130.4, 133.7 (d, J = 3.8 Hz), 136.8, 138.0, 141.4, 154.5, 158.1, 158.3, 160.6.; 19F-NMR (CDCl3) δ: -17.8.
(E)-3-tert-butyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C5) 1H-NMR (CDCl3) δ: 8.62 (1H, d, J= 3.7 Hz), 8.02 (2H, dd, J = 6.9, 1.8 Hz), 7.83-7.80 (2H, m), 7.70 (3H, ddd, J = 12.6, 5.7, 3.9 Hz), 7.64 (1H, s), 7.54 (1H, t, J = 1.6 Hz), 7.44 (1H, d, J = 7.8 Hz), 7.26 (1H, t, J = 8.0 Hz), 7.19-7.16 (1H, m), 4.05 (2H, s), 3.43-3.40 (2H, m), 2.93 (1H, s), 1.41 (9H, s).; 13C-NMR (CDCl3) δ: 31.3, 34.9, 56.4, 58.4, 122.0, 122.2, 123.2, 124.6, 124.9, 127.9, 128.2, 128.5, 129.4, 132.6, 136.6, 137.2, 137.4, 139.3, 147.5, 149.7, 152.6, 155.4.
(E)-4'-(2-hydroxyethanesulfonyl)-3-methyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C6) 1H-NMR (CDCl3) δ: 8.60 (1H, d, J= 3.7 Hz), 7.98 (2H, dd, J = 6.9, 1.8 Hz), 7.77 (2H, t, J = 4.4 Hz), 7.70-7.62 (2H, m), 7.58 (1H, s), 7.42 (2H, t, J = 9.6 Hz), 7.33 (1H, s), 7.24 (1H, t, J = 13.5 Hz), 7.17 (1H, td, J = 6.2, 1.1 Hz), 4.04 (2H, t, J = 5.7 Hz), 3.41 (3H, t, J = 5.5 Hz), 2.44 (3H, s).; 13C-NMR (CDCl3) δ: 21.4, 56.2, 58.3, 122.1, 122.2, 123.4, 127.9, 128.1, 128.4, 128.4, 128.5, 131.9, 132.0, 132.1, 136.6, 137.3, 137.5, 139.1, 139.4, 146.7, 149.5, 155.2.
(E)-4'-(2-hydroxyethanesulfonyl)-3-(pyridin-2-yl-2-vinyl)-5-trifluoromethyl-1,1'-biphenyl (C7) 1H-NMR (CDCl3) δ: 8.63 (1H, dd, J= 5.0, 0.9 Hz), 8.05 (2H, dt, J = 8.7, 1.8 Hz), 7.91 (2H, d, J = 28.9 Hz), 7.82 (2H, dt, J = 8.5, 2.1 Hz), 7.72 (3H, dd, J = 8.9, 7.1 Hz), 7.44 (1H, d, J = 7.8 Hz), 7.30 (1H, t, J = 10.1 Hz), 7.22 (1H, ddd, J = 7.6, 4.8, 0.9 Hz), 4.07 (2H, t, J = 4.8 Hz), 3.45-3.42 (2H, m), 3.21 (1H, s).; 13C-NMR (CDCl3) δ: 56.2, 58.4, 122.7 (d, J= 19.2 Hz), 123.5, 124.3 (d, J = 5.8 Hz), 125.1, 128.2, 128.7, 129.0 (d, J = 29.7 Hz), 130.5 (d, J = 1.9 Hz), 132.0 (q, J = 32.3 Hz), 136.4 (t, J = 253.5 Hz), 136.8, 138.5 (d, J = 6.7 Hz), 140.3, 142.3 (t, J = 205.6 Hz), 145.2, 149.7, 150.2, 154.5.; 19F-NMR (CDCl3) δ: 37.4.
(E)-4'-(2-hydroxyethanesulfonyl)-4-methyl-3-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C8) 1H-NMR (CDCl3) δ: 8.61 (1H, t, J= 2.5 Hz), 7.98 (2H, dt, J = 8.4, 1.9 Hz), 7.90 (2H, dd, J = 13.1, 8.9 Hz), 7.80 (2H, dt, J = 8.7, 1.8 Hz), 7.69 (1H, td, J = 7.6, 1.8 Hz), 7.45-7.41 (2H, m), 7.30 (1H, d, J = 7.8 Hz), 7.16 (2H, tt, J = 6.2, 3.8 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.42-3.39 (2H, m), 3.33 (1H, s), 2.52 (3H, s).; 13C-NMR (CDCl3) δ: 19.7, 56.3, 58.3, 122.2, 122.3, 124.6, 126.9, 127.8, 128.4, 129.9, 130.0, 131.3, 131.9, 136.4, 136.6, 136.8, 137.2, 137.3, 146.7, 149.6, 155.3.
(E)-4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl-2-vinyl)-1,1'-biphenyl (C9) 1H-NMR (CDCl3) δ: 8.48 (1H, d, J = 4.6 Hz), 8.01 (2H, d, J = 8.7 Hz), 7.83 (4H, dt, J = 14.8, 7.1 Hz), 7.68 (1H, t, J = 3.7 Hz), 7.51 (3H, tt, J = 11.4, 2.7 Hz), 7.42 (1H, d, J = 15.6 Hz), 7.11 (1H, dd, J = 7.6, 4.8 Hz), 4.05 (2H, t, J = 5.5 Hz), 3.42-3.40 (2H, m), 3.01 (1H, s), 2.47 (3H, s).; 13C-NMR (CDCl3) δ: 18.9, 56.4, 58.4, 122.4, 125.0, 126.3, 127.2, 127.3, 128.1, 128.5, 129.5, 131.0, 132.9, 137.6, 138.0, 138.3, 139.5, 146.9, 147.1, 153.1.
(E)-4'-(2-hydroxyethanesulfonyl)-3-(6-methylpyridin-2-yl-2-vinyl)-4-methyl-1,1'-biphenyl (C10) 1H-NMR (CDCl3) δ: 7.99 (2H, dt, J = 8.7, 2.1 Hz), 7.89 (1H, d, J = 2.3 Hz), 7.86-7.80 (3H, m), 7.58 (1H, t, J = 7.8 Hz), 7.45 (1H, dd, J= 7.8, 2.3 Hz), 7.30 (2H, t, J = 8.5 Hz), 7.16 (1H, d, J = 16.0 Hz), 7.05 (1H, d, J = 7.3 Hz), 4.06-4.03 (2H, m), 3.42-3.39 (2H, m), 2.95 (1H, s), 2.60 (3H, s), 2.53 (3H, s).; 13C-NMR (CDCl3) δ: 19.7, 24.6, 56.4, 58.4, 118.8, 122.0, 124.7, 126.8, 127.8, 128.5, 129.5, 130.6, 131.3, 136.7, 136.7, 136.9, 137.2, 146.9, 155.0, 158.4.
(E)-4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl-2-vinyl)-4-methyl-1,1'-biphenyl (C11) 1H-NMR (CDCl3) δ: 8.48 (1H, dd, J = 4.8, 1.6 Hz), 8.05 (1H, d, J = 15.1 Hz), 8.00 (2H, dt, J = 8.7, 1.8 Hz), 7.84 (1H, d, J = 1.8 Hz), 7.81 (2H, dt, J = 8.5, 1.9 Hz), 7.46 (3H, tt, J = 10.1, 2.9 Hz), 7.32 (2H, d, J = 7.3 Hz), 7.27 (1H, d, J = 2.3 Hz), 7.11 (1H, dd, J = 7.8, 4.6 Hz), 4.04 (2H, t, J = 5.3 Hz), 3.41-3.39 (2H, m), 3.10 (1H, s), 2.54 (3H, s), 2.45 (3H, s).; 13C-NMR (CDCl3) δ: 18.9, 19.8, 56.3, 58.4, 122.3, 124.8, 126.4, 126.8, 127.9, 128.5, 128.6, 131.0, 131.1, 131.3, 132.0, 136.9, 137.2, 137.2, 137.6, 138.3, 146.9, 147.1, 153.3.
(E)-4'-(2-hydroxyethanesulfonyl)-2-methyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C12) 1H-NMR (CDCl3) δ: 8.58 (1H, t, J= 2.5 Hz), 7.99 (2H, d, J = 8.1 Hz), 7.64 (2H, ddd, J = 16.8, 8.9, 5.5 Hz), 7.57-7.52 (3H, m), 7.42 (1H, d, J = 1.6 Hz), 7.38 (1H, d, J= 8.1 Hz), 7.31 (1H, d, J = 7.9 Hz), 7.16 (2H, dt, J = 10.4, 3.9 Hz), 4.07 (2H, t, J = 5.6 Hz), 3.45-3.43 (2H, m), 3.29 (1H, br s), 2.26 (3H, s).; 13C-NMR (CDCl3) δ: 20.2, 56.3, 58.3, 122.1, 122.1, 126.9, 127.7, 127.9, 128.0, 130.2, 131.9, 131.9, 132.0, 134.6, 135.4, 136.6, 137.4, 140.1, 147.7, 149.5, 153.3.
(E)-4'-(2-hydroxyethanesulfonyl)-4-propyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C14) 1H-NMR (CDCl3) δ: 8.62 (1H, dd, J= 4.8, 0.9 Hz), 8.00-7.97 (2H, m), 7.94 (1H, d, J = 15.9 Hz), 7.89 (1H, d, J = 2.0 Hz), 7.81 (2H, dd, J = 6.8, 2.0 Hz), 7.70 (1H, td, J= 7.7, 1.8 Hz), 7.46 (3H, dt, J = 15.8, 6.4 Hz), 7.31 (1H, d, J = 7.9 Hz), 7.20-7.13 (2H, m), 4.04 (2H, t, J = 5.6 Hz), 3.42-3.40 (2H, m), 3.29 (1H, s), 2.83 (2H, t, J = 7.7 Hz), 1.69 (2H, dd, J = 15.2, 7.5 Hz), 1.01 (3H, t, J = 7.3 Hz).; 13C-NMR (CDCl3) δ: 14.0, 24.2, 35.1, 56.3, 58.3, 122.1, 122.3, 124.9, 126.9, 127.8, 128.4, 128.5, 129.9, 130.1, 130.6, 132.0, 136.1, 136.6, 136.8, 137.2, 141.9, 146.7, 149.6, 155.4.
(E)-4-ethoxy-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C15) 1H-NMR (CDCl3) δ: 8.61 (1H, t, J= 2.4 Hz), 7.98-7.92 (3H, m), 7.88 (1H, d, J = 2.3 Hz), 7.78 (2H, dt, J= 8.6, 2.0 Hz), 7.68 (1H, td, J = 7.7, 1.8 Hz), 7.51 (1H, dd, J = 8.6, 2.5 Hz), 7.47 (1H, d, J = 8.0 Hz), 7.35 (1H, d, J = 16.2 Hz), 7.16 (1H, ddd, J = 7.5, 4.8, 1.1 Hz), 7.01 (1H, d, J = 8.6 Hz), 4.20 (2H, q, J = 7.0 Hz), 4.05 (2H, t, J = 5.4 Hz), 3.40 (2H, td, J = 4.1, 2.1 Hz), 2.97 (1H, br s), 1.54 (3H, t, J = 7.0 Hz).; 13C-NMR (CDCl3) δ: 14.8, 56.4, 58.4, 64.2, 112.4, 121.8, 122.0, 126.4, 126.5, 127.4, 127.5, 128.2, 128.5, 129.6, 131.1, 136.5, 136.7, 146.6, 149.6, 156.0, 157.5.
(E)-4'-(2-hydroxyethanesulfonyl)-4-pentyl-3-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C16) 1H-NMR (CDCl3) δ: 8.62 (1H, d, J= 4.1 Hz), 7.99 (2H, d, J = 8.7 Hz), 7.93 (1H, d, J = 15.6 Hz), 7.88 (1H, d, J = 1.8 Hz), 7.81 (2H, d, J = 8.7 Hz), 7.69 (1H, td, J = 7.8, 1.8 Hz), 7.48 (1H, dd, J = 7.8, 1.8 Hz), 7.43 (1H, d, J= 8.2 Hz), 7.31 (1H, d, J = 8.2 Hz), 7.16 (2H, dd, J = 13.7, 9.2 Hz), 4.04 (2H, d, J = 5.5 Hz), 3.41 (2H, t, J = 5.5 Hz), 3.18 (1H, s), 2.84 (2H, t, J = 7.8 Hz), 1.65 (2H, dd, J = 15.1, 7.3 Hz), 1.38 (4H, t, J = 3.7 Hz), 0.90 (3H, t, J = 7.1 Hz).; 13C-NMR (CDCl3) δ: 14.0, 22.4, 30.7, 31.6, 33.0, 56.3, 58.4, 122.0, 122.2, 125.0, 126.9, 127.8, 128.5, 129.9, 130.2, 130.5, 136.1, 136.6, 136.8, 137.2, 142.1, 146.8, 149.7, 155.5.
(E)-4'-(2-hydroxyethanesulfonyl)-4-iso-propyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C17) 1H-NMR (CDCl3) δ: 8.62 (1H, d, J= 3.7 Hz), 8.06 (1H, d, J = 16.0 Hz), 7.99 (2H, d, J = 8.7 Hz), 7.83 (3H, dd, J = 11.4, 5.0 Hz), 7.69 (1H, td, J = 7.7, 1.7 Hz), 7.54 (1H, dd, J = 8.0, 2.1 Hz), 7.43 (2H, t, J = 8.2 Hz), 7.18 (1H, dd, J = 7.1, 5.3 Hz), 7.11 (1H, d, J = 15.6 Hz), 4.05 (2H, t, J = 5.3 Hz), 3.51-3.44 (1H, m), 3.41 (2H, dd, J = 6.9, 4.1 Hz), 3.16 (1H, s), 1.32 (6H, d, J = 6.4 Hz).; 13C-NMR (CDCl3) δ: 23.5, 29.1, 56.3, 58.4, 122.3, 122.3, 125.4, 126.1, 127.3, 127.8, 128.5, 130.0, 130.7, 135.8, 136.5, 136.6, 137.2, 146.7, 147.7, 149.7, 155.4.
(E)-4-iso-butyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C18) 1H-NMR (CDCl3) δ: 8.61 (1H, d, J= 4.1 Hz), 7.99 (2H, d, J = 8.2 Hz), 7.92 (2H, dd, J = 10.8, 8.9 Hz), 7.82 (2H, d, J = 8.7 Hz), 7.69 (1H, td, J = 7.6, 1.7 Hz), 7.47 (1H, dd, J = 7.8, 1.8 Hz), 7.43 (1H, d, J = 7.8 Hz), 7.27 (1H, t, J = 3.9 Hz), 7.19-7.13 (2H, m), 4.04 (2H, t, J = 5.3 Hz), 3.41 (2H, t, J = 5.5 Hz), 3.21 (1H, s), 2.72 (2H, d, J = 7.3 Hz), 1.98-1.91 (1H, m), 0.97 (6H, d, J = 6.4 Hz).; 13C-NMR (CDCl3) δ: 22.5, 30.0, 42.3, 56.3, 58.4, 121.9, 122.2, 125.0, 126.6, 127.8, 128.5, 130.1, 130.2, 131.5, 136.4, 136.6, 136.8, 137.3, 141.0, 146.7, 149.7, 155.5.
(E)-4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl-2-vinyl)-4-propyl-1,1'-biphenyl (C19) 1H-NMR (CDCl3) δ: 8.48 (1H, dd, J = 4.7, 1.6 Hz), 8.08 (1H, d, J = 15.6 Hz), 8.00 (2H, dt, J = 8.6, 2.0 Hz), 7.82 (3H, dq, J = 10.0, 2.5 Hz), 7.49-7.47 (2H, m), 7.33-7.25 (3H, m), 7.11 (1H, dd, J = 7.6, 4.8 Hz), 4.05-4.03 (2H, m), 3.40 (2H, dt, J = 5.8, 2.5 Hz), 3.08 (1H, s), 2.84 (2H, t, J = 7.7 Hz), 2.45 (3H, s), 1.70 (2H, dd, J = 15.3, 7.4 Hz), 1.01 (3H, t, J = 7.3 Hz).; 13C-NMR (CDCl3) δ: 13.9, 18.9, 24.0, 35.0, 56.1, 58.3, 122.2, 125.0, 126.4, 126.8, 127.7, 128.4, 130.4, 130.9, 131.1, 136.7, 136.7, 137.2, 138.3, 142.0, 146.7, 147.0, 153.3.
(E)-4'-(2-hydroxyethanesulfonyl)-3-(3-penthylpyridin-2-yl-2-vinyl)-4-propyl-1,1'-biphenyl (C21) 1H-NMR (CDCl3) δ: 8.49 (1H, dd, J = 4.8, 1.7 Hz), 8.09 (1H, d, J = 15.4 Hz), 8.00 (2H, dt, J = 8.6, 2.0 Hz), 7.84-7.80 (3H, m), 7.48 (2H, dt, J = 7.8, 2.0 Hz), 7.33 (2H, t, J = 4.6 Hz), 7.27 (1H, d, J= 4.6 Hz), 7.13 (1H, dd, J = 7.7, 4.7 Hz), 4.06-4.04 (2H, m), 3.42-3.39 (2H, m), 3.08 (1H, s), 2.84 (2H, t, J = 7.7 Hz), 2.75 (2H, t, J = 7.8 Hz), 1.75-1.60 (4H, m), 1.40-1.34 (4H, m), 1.01 (3H, t, J = 7.3 Hz), 0.90-0.87 (3H, m).; 13C-NMR (CDCl3) δ: 14.0, 14.0, 22.4, 24.1, 30.5, 31.5, 32.3, 35.1, 56.3, 58.4, 122.3, 125.2, 126.6, 126.8, 127.8, 128.5, 130.5, 131.2, 135.6, 136.8, 137.1, 137.2, 137.5, 142.1, 147.0, 147.2, 152.9.
(E)-4-heptyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C22) 1H-NMR (CDCl3) δ: 8.63-8.61 (1H, m), 8.00-7.98 (2H, m), 7.94 (1H, d, J = 16.0 Hz), 7.89 (1H, d, J = 1.8 Hz), 7.82 (2H, dt, J = 8.5, 1.9 Hz), 7.70 (1H, td, J = 7.8, 1.8 Hz), 7.48 (1H, dd, J = 8.0, 2.1 Hz), 7.43 (1H, d, J = 7.8 Hz), 7.32 (1H, d, J = 8.2 Hz), 7.17 (2H, tt, J = 6.2, 3.7 Hz), 4.05 (2H, d, J = 4.6 Hz), 3.42-3.39 (2H, m), 3.14 (1H, s), 2.84 (2H, t, J= 7.8 Hz), 1.69-1.62 (2H, m), 1.44-1.22 (8H, m), 0.87 (3H, t, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 14.1, 22.6, 29.1, 29.4, 31.1, 31.7, 33.1, 56.3, 58.4, 122.0, 122.3, 125.0, 126.9, 127.8, 128.5, 129.9, 130.2, 130.5, 136.1, 136.6, 136.8, 137.2, 142.2, 146.8, 149.7, 155.5.
(E)-4'-(2-hydroxyethanesulfonyl)-4-octyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C23) 1H-NMR (CDCl3) δ: 8.62 (1H, dd, J= 5.0, 0.9 Hz), 7.99 (2H, t, J = 4.4 Hz), 7.93 (1H, d, J = 16.0 Hz), 7.89 (1H, d, J = 1.8 Hz), 7.81 (2H, dd, J = 8.7, 1.8 Hz), 7.69 (1H, td, J = 7.6, 1.8 Hz), 7.46 (2H, td, J = 10.1, 4.0 Hz), 7.31 (1H, d, J = 7.8 Hz), 7.20-7.14 (2H, m), 4.04 (2H, d, J = 3.7 Hz), 3.40 (2H, td, J = 6.5, 4.1 Hz), 3.27 (1H, s), 2.84 (2H, t, J = 7.8 Hz), 1.69-1.61 (2H, m), 1.44-1.26 (10H, m), 0.86 (3H, t, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 14.0, 22.6, 29.2, 29.3, 29.4, 31.0, 31.8, 33.0, 56.3, 58.3, 122.0, 122.2, 124.9, 126.0, 127.8, 128.5, 129.9, 130.2, 130.5, 136.0, 136.6, 136.7, 137.2, 142.1, 146.7, 149.6, 155.5.
(E)-4-cyclo-hexyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (C24) 1H-NMR (CDCl3) δ: 8.62 (1H, d, J= 4.1 Hz), 8.02 (1H, d, J = 16.0 Hz), 7.98 (2H, dt, J = 8.5, 2.1 Hz), 7.85 (1H, d, J = 2.3 Hz), 7.80 (2H, d, J = 8.2 Hz), 7.70 (1H, td, J = 7.6, 1.7 Hz), 7.52 (1H, dd, J = 8.2, 1.8 Hz), 7.42 (2H, t, J = 8.9 Hz), 7.19 (1H, dd, J = 7.1, 4.4 Hz), 7.11 (1H, d, J = 15.6 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.41 (2H, t, J = 5.5 Hz), 3.34 (1H, s), 3.05-2.99 (1H, m), 1.89 (4H, t, J = 9.2 Hz), 1.80 (1H, d, J = 13.7 Hz), 1.49 (4H, t, J = 10.3 Hz), 1.34-1.25 (1H, m).; 13C-NMR (CDCl3) δ: 26.1, 26.8, 33.9, 39.7, 56.2, 58.3, 122.1, 122.3, 125.4, 126.7, 127.1, 127.8, 128.4, 130.1, 130.7, 135.8, 136.4, 136.7, 137.2, 146.7, 146.7, 149.6, 155.5.
(E)-4'-(2-hydroxyethanesulfonyl)-4-cyclo-pentyl-5-(pyridin-2-ylethyl)-1,1'-biphenyl (C25) 1H-NMR (CDCl3) δ: 8.62 (1H, d, J= 3.9 Hz), 8.05 (1H, d, J = 15.8 Hz), 7.98 (2H, dt, J = 8.5, 1.8 Hz), 7.84 (1H, d, J = 2.1 Hz), 7.81 (2H, dt, J = 8.5, 1.8 Hz), 7.69 (1H, td, J = 7.7, 1.8 Hz), 7.52 (1H, dd, J = 8.1, 1.9 Hz), 7.43 (2H, dd, J = 8.0, 4.8 Hz), 7.18 (1H, ddd, J = 7.6, 4.8, 0.9 Hz), 7.10 (1H, d, J = 15.8 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.53-3.44 (1H, m), 3.42-3.39 (2H, m), 3.30 (1H, s), 2.12 (2H, dt, J = 15.3, 5.6 Hz), 1.89-1.61 (6H, m).; 13C-NMR (CDCl3) δ: 25.6, 34.2, 41.4, 56.3, 58.3, 122.3, 125.2, 126.7, 127.1, 127.8, 128.5, 130.4, 130.5, 136.4, 136.5, 136.7, 137.2, 145.5, 146.7, 149.6, 155.4.
(4)D1〜D25の合成
D1〜D25の合成は下記合成法により合成した。
合成したD1〜D25のNMRを下記に示す。
(Z)-4'-(2-hydroxyethanesulfonyl)-3-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D1) 1H-NMR (CDCl3) δ: 8.63 (1H, d, J= 4.5 Hz), 8.01 (2H, d, J = 7.9 Hz), 7.82 (3H, d, J = 8.5 Hz), 7.69 (3H, dt, J = 24.6, 8.2 Hz), 7.53 (2H, dd, J = 16.4, 7.4 Hz), 7.42 (1H, d, J = 7.9 Hz), 7.26 (1H, d, J = 15.9 Hz), 7.19 (1H, dd, J = 7.4, 4.5 Hz), 4.56 (2H, t, J = 6.2 Hz), 3.54 (2H, t, J= 6.2 Hz).; 13C-NMR (CDCl3) δ: 54.9, 57.0, 122.3, 122.3, 126.0, 127.2, 127.4, 128.0, 128.7, 128.8, 129.5, 131.9, 136.7, 137.5, 137.6, 139.4, 146.8, 149.7, 155.1, 160.0.
(Z)-2-fluoro-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D2) 1H-NMR (CDCl3) δ: 8.60 (1H, d, J= 4.1 Hz), 8.02 (2H, t, J = 4.4 Hz), 7.78 (2H, dd, J = 8.2, 1.4 Hz), 7.71-7.58 (4H, m), 7.39 (1H, d, J = 7.8 Hz), 7.22-7.13 (3H, m), 4.06 (2H, t, J = 5.5 Hz), 3.43 (2H, t, J = 5.5 Hz), 3.28 (1H, s).; 13C-NMR (CDCl3) δ: 56.2, 58.3, 116.8 (d, J = 23.0 Hz), 122.3 (d, J = 14.4 Hz), 127.2 (d, J = 14.4 Hz), 128.1, 128.4, 128.9 (d, J = 8.6 Hz), 129.9 (d, J = 3.8 Hz), 133.5 (d, J = 3.8 Hz),136.7, 138.1, 141.4 (d, J = 1.9 Hz), 149.6, 155.0, 158.2, 160.4.
(Z)-4'-(2-hydroxyethanesulfonyl)-3-(6-methylpyridin-2-yl-2-vinyl)-1,1'-biphenyl (D3) 1H-NMR (CDCl3) δ: 7.98 (2H, dd, J = 6.4, 1.8 Hz), 7.76 (3H, t, J = 4.1 Hz), 7.63-7.55 (3H, m), 7.47 (2H, tt, J = 8.9, 3.6 Hz), 7.25 (2H, dd, J = 16.5, 9.2 Hz), 7.03 (1H, d, J = 7.8 Hz), 4.03 (2H, t, J= 5.7 Hz), 3.44 (1H, br s), 3.42-3.40 (2H, m), 2.58 (3H, s).; 13C-NMR (CDCl3) δ: 24.4, 56.0, 58.2, 118.8, 122.0, 125.9, 127.0, 127.1, 127.9, 128.4, 129.0, 129.3, 131.6, 136.8, 137.4, 137.5, 139.2, 146.4, 154.5, 158.2.
(Z)-2-fluoro-4'-(2-hydroxyethanesulfonyl)-5-(6-methylpyridin-2-yl-2-vinyl)-1,1'-biphenyl (D4) 1H-NMR (CDCl3) δ: 8.01-7.98 (2H, m), 7.75 (2H, dd, J = 8.5, 1.1 Hz), 7.63 (1H, dd, J = 7.3, 2.3 Hz), 7.57 (3H, dq, J = 13.2, 3.5 Hz), 7.24 (1H, d, J = 7.8 Hz), 7.16 (2H, dt, J = 15.9, 6.6 Hz), 7.04 (1H, d, J = 7.8 Hz), 4.04 (2H, t, J = 5.7 Hz), 3.47 (1H, s), 3.42 (2H, t, J = 5.7 Hz), 2.57 (3H, s).; 13C-NMR (CDCl3) δ: 24.3, 56.0, 58.2, 116.7 (d, J = 23.0 Hz), 118.9, 122.0, 127.0 (d, J = 13.4 Hz), 128.0, 128.7 (d, J = 2.9 Hz), 128.7, 129.0 (d, J = 2.9 Hz), 129.8 (d, J= 2.9 Hz), 130.5, 133.5 (d, J = 3.8 Hz), 136.8, 138.0, 141.2, 154.4, 158.0, 158.2, 160.5.; 19F-NMR (CDCl3) δ: -17.7.
(Z)-3-tert-butyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D5) 1H-NMR (CDCl3) δ: 8.62 (1H, d, J= 4.1 Hz), 8.02 (2H, t, J = 4.4 Hz), 7.82 (2H, t, J = 4.1 Hz), 7.70 (3H, ddd, J = 13.1, 6.4, 3.9 Hz), 7.64 (1H, s), 7.54 (1H, t, J= 1.6 Hz), 7.44 (1H, d, J = 7.8 Hz), 7.26 (2H, t, J = 8.0 Hz), 7.18 (1H, ddd, J = 7.6, 4.8, 0.9 Hz), 4.05 (2H, t, J = 5.3 Hz), 3.41 (2H, t, J = 5.3 Hz), 2.89 (1H, t, J = 1.8 Hz), 1.41 (9H, s).; 13C-NMR (CDCl3) δ: 31.3, 34.9, 56.4, 58.4, 122.1, 122.3, 123.2, 124.6, 124.9, 128.3, 128.5, 128.6, 132.5, 136.6, 137.2, 137.4, 139.3, 147.5, 149.7, 152.6, 155.4.
(Z)-4'-(2-hydroxyethanesulfonyl)-3-methyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D6) 1H-NMR (CDCl3) δ: 8.59 (1H, d, J= 4.1 Hz), 7.92 (2H, t, J = 4.1 Hz), 7.60 (2H, t, J = 4.1 Hz), 7.50 (1H, td, J = 7.8, 1.8 Hz), 7.29 (2H, t, J = 8.0 Hz), 7.22 (1H, d, J = 7.8 Hz), 7.14 (2H, t, J = 5.7 Hz), 6.83 (1H, d, J= 12.4 Hz), 6.74 (1H, d, J = 12.8 Hz), 4.02 (2H, t, J = 5.5 Hz), 3.38 (2H, dd, J = 6.6, 4.4 Hz), 3.31 (1H, s), 2.36 (3H, s).; 13C-NMR (CDCl3) δ: 21.3, 56.2, 58.3, 122.0, 124.0, 125.2, 127.3, 127.8, 128.4, 130.0, 130.8, 132.7, 135.8, 137.2, 137.3, 138.7, 138.8, 146.7, 149.5, 156.1.
(Z)-4'-(2-hydroxyethanesulfonyl)-3-(pyridin-2-yl-2-vinyl)-5-trifluoromethyl-1,1'-biphenyl (D7) 1H-NMR (CDCl3) δ: 8.63 (1H, dd, J= 4.8, 1.1 Hz), 8.05 (2H, dt, J = 8.7, 1.8 Hz), 7.91 (2H, d, J = 28.9 Hz), 7.82-7.80 (2H, m), 7.72 (3H, dd, J = 8.7, 6.9 Hz), 7.44 (1H, d, J = 7.8 Hz), 7.30 (1H, t, J = 9.8 Hz), 7.22 (1H, ddd, J= 7.4, 4.7, 1.0 Hz), 4.07 (2H, t, J = 5.0 Hz), 3.45-3.42 (2H, m), 3.26 (1H, s).; 13C-NMR (CDCl3) δ: 56.2, 58.4, 122.7 (d, J = 19.2 Hz), 123.5 (q, J = 1.9 Hz), 123.6 (q, J = 272.8 Hz), 128.2, 128.7, 129.1, 130.5, 132.0 (d, J= 9.6 Hz), 132.0 (q, J = 32.6 Hz), 136.8, 138.5, 138.6, 140.3, 145.2, 149.8, 154.5.; 19F-NMR (CDCl3) δ: 37.4.
(Z)-4'-(2-hydroxyethanesulfonyl)-4-methyl-3-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D8) 1H-NMR (CDCl3) δ: 8.56 (1H, dq, J= 5.0, 0.9 Hz), 7.89 (2H, dt, J = 8.5, 2.1 Hz), 7.54 (2H, dt, J = 8.7, 2.1 Hz), 7.41 (3H, tt, J = 12.1, 4.0 Hz), 7.33 (1H, d, J = 8.2 Hz), 7.08 (1H, ddd, J = 7.4, 4.9, 1.0 Hz), 6.99 (1H, d, J = 7.8 Hz), 6.93 (1H, d, J = 12.4 Hz), 6.84 (1H, d, J = 12.4 Hz), 4.01 (2H, t, J = 5.3 Hz), 3.38-3.35 (2H, m), 3.28 (1H, s), 2.35 (3H, s).; 13C-NMR (CDCl3) δ: 19.6, 56.2, 58.3, 121.9, 123.5, 126.4, 127.5, 127.9, 128.4, 131.0, 131.7, 132.0, 135.7, 136.2, 137.0, 137.1, 146.4, 149.4, 155.9.
(Z)-4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl-2-vinyl)-1,1'-biphenyl (D9) 1H-NMR (CDCl3) δ: 8.47 (1H, dd, J = 4.6, 1.4 Hz), 8.00 (2H, dt, J = 8.4, 1.9 Hz), 7.86-7.78 (4H, m), 7.67 (1H, dt, J = 7.0, 1.6 Hz), 7.50 (3H, dq, J = 12.7, 4.0 Hz), 7.41 (1H, d, J = 15.6 Hz), 7.10 (1H, dd, J = 7.6, 4.8 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.42-3.39 (2H, m), 3.18 (1H, s), 2.46 (3H, s).; 13C-NMR (CDCl3) δ: 18.8, 56.3, 58.3, 122.3, 124.9, 126.2, 127.1, 127.2, 128.0, 128.5, 129.4, 131.0, 132.9, 137.6, 137.9, 138.3, 139.4, 146.7, 147.1, 153.0.
(Z)-4'-(2-hydroxyethanesulfonyl)-3-(6-methylpyridin-2-yl-2-vinyl)-4-methyl-1,1'-biphenyl (D10) 1H-NMR (CDCl3) δ: 8.01-7.98 (2H, m), 7.89 (1H, d, J = 1.8 Hz), 7.87-7.81 (3H, m), 7.58 (1H, t, J = 7.8 Hz), 7.45 (1H, dd, J = 7.8, 1.8 Hz), 7.30 (2H, dd, J = 11.2, 8.0 Hz), 7.16 (1H, d, J = 16.0 Hz), 7.05 (1H, d, J = 7.8 Hz), 4.05 (2H, t, J = 5.3 Hz), 3.42-3.39 (2H, m), 2.85 (1H, s), 2.60 (3H, s), 2.53 (3H, s).; 13C-NMR (CDCl3) δ: 19.8, 24.7, 56.4, 58.4, 118.8, 122.0, 124.7, 126.8, 127.9, 128.5, 129.5, 130.7, 131.3, 136.7, 136.7, 136.9, 137.2, 137.2, 146.9, 155.0, 158.4.
(Z)-4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl-2-vinyl)-4-methyl-1,1'-biphenyl (D11) 1H-NMR (CDCl3) δ: 8.45 (1H, t, J = 2.3 Hz), 7.82 (2H, dt, J = 8.7, 1.8 Hz), 7.43 (1H, d, J = 6.9 Hz), 7.29 (5H, ddt, J = 18.1, 9.8, 3.9 Hz), 7.13 (1H, dd, J = 7.6, 4.8 Hz), 7.06 (1H, d, J = 1.8 Hz), 6.96 (1H, d, J = 12.4 Hz), 6.86 (1H, d, J = 11.9 Hz), 4.00 (2H, d, J = 5.0 Hz), 3.34 (2H, td, J = 4.1, 2.0 Hz), 2.90 (1H, s), 2.41 (3H, s), 2.05 (3H, s).; 13C-NMR (CDCl3) δ: 18.6, 19.6, 56.4, 58.3, 122.1, 126.1, 127.4, 128.1, 129.6, 130.9, 131.4, 131.5, 135.6, 136.6, 136.8, 137.1, 138.0, 146.6, 147.0, 155.9.
(Z)-4'-(2-hydroxyethanesulfonyl)-2-methyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D12) 1H-NMR (CDCl3) δ: 8.55 (1H, dq, J= 4.9, 0.9 Hz), 7.93 (2H, dt, J = 8.6, 1.9 Hz), 7.52 (1H, td, J = 7.7, 1.7 Hz), 7.42 (2H, dt, J = 8.6, 1.9 Hz), 7.26-7.11 (5H, m), 6.79 (1H, d, J = 12.4 Hz), 6.67 (1H, d, J = 12.4 Hz), 4.04 (2H, t, J= 5.6 Hz), 3.63 (1H, s), 3.43-3.40 (2H, m), 2.23 (3H, s).; 13C-NMR (CDCl3) δ: 14.0, 23.7, 35.4, 56.2, 58.3, 121.8, 123.6, 126.5, 127.5, 128.3, 128.4, 130.3, 131.7, 132.1, 135.7, 136.2, 136.6, 137.1, 141.7, 146.4, 149.5, 155.8.
(Z)-4'-(2-hydroxyethanesulfonyl)-4-propyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D14) 1H-NMR (CDCl3) δ: 8.57 (1H, dq, J= 5.0, 1.0 Hz), 7.88 (2H, dt, J = 8.6, 2.0 Hz), 7.53-7.51 (2H, m), 7.46 (1H, dd, J = 8.0, 1.9 Hz), 7.40-7.34 (3H, m), 7.08 (1H, ddd, J = 7.5, 4.9, 1.0 Hz), 6.99 (2H, dd, J = 16.1, 10.2 Hz), 6.84 (1H, d, J= 12.4 Hz), 4.00 (2H, t, J = 5.5 Hz), 3.38-3.35 (3H, m), 2.68 (2H, dd, J= 8.6, 6.9 Hz), 1.70-1.64 (2H, m), 1.00 (3H, t, J = 7.2 Hz).; 13C-NMR (CDCl3) δ: 20.1, 56.1, 58.2, 121.9, 123.9, 127.7, 128.7, 130.0, 130.0, 130.1, 130.6, 132.5, 134.2, 134.6, 135.8, 137.3, 139.5, 147.5, 149.3, 156.1.
(Z)-4-ethoxy-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D15) 1H-NMR (CDCl3) δ: 8.62 (1H, dq, J= 4.8, 0.9 Hz), 7.97 (3H, dt, J = 13.7, 5.8 Hz), 7.89 (1H, d, J = 2.4 Hz), 7.80 (2H, dt, J = 8.7, 2.0 Hz), 7.68 (1H, td, J = 7.7, 1.8 Hz), 7.52 (1H, dd, J = 8.6, 2.4 Hz), 7.47 (1H, t, J = 4.0 Hz), 7.35 (1H, d, J = 16.4 Hz), 7.16 (1H, ddd, J = 7.5, 4.8, 1.1 Hz), 7.02 (1H, d, J = 8.6 Hz), 4.20 (2H, q, J = 7.0 Hz), 4.05 (2H, s), 3.42-3.39 (2H, m), 1.55 (3H, t, J = 7.0 Hz).; 13C-NMR (CDCl3) δ: 14.8, 56.5, 58.4, 64.2, 112.4, 121.9, 122.1, 126.5, 126.6, 127.5, 128.2, 128.6, 129.7, 131.1, 136.5, 136.7, 146.6, 149.7, 156.0, 157.5, 158.7.
(E)-4'-(2-hydroxyethanesulfonyl)-4-pentyl-3-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D16) 1H-NMR (CDCl3) δ: 8.57 (1H, d, J= 4.1 Hz), 7.88 (2H, d, J = 8.7 Hz), 7.52 (2H, d, J = 8.7 Hz), 7.46 (1H, dd, J = 8.0, 2.1 Hz), 7.36 (3H, td, J = 9.8, 4.0 Hz), 7.07 (1H, t, J = 6.2 Hz), 6.99 (2H, dd, J = 14.7, 10.1 Hz), 6.84 (1H, d, J = 12.4 Hz), 4.00 (2H, t, J = 5.7 Hz), 3.36 (3H, t, J= 5.5 Hz), 2.69 (2H, t, J = 7.8 Hz), 1.63 (2H, t, J = 7.6 Hz), 1.35 (4H, dd, J = 7.3, 3.7 Hz), 0.89 (3H, t, J = 7.1 Hz).; 13C-NMR (CDCl3) δ: 13.9, 22.4, 30.1, 31.6, 33.3, 56.2, 58.3, 121.8, 123.6, 126.5, 127.5, 128.3, 128.4, 130.2, 131.7, 132.1, 135.6, 136.2, 136.5, 137.1, 142.0, 146.4, 149.4, 155.9.
(Z)-4'-(2-hydroxyethanesulfonyl)-4-iso-propyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D17) 1H-NMR (CDCl3) δ: 8.56 (1H, dq, J= 5.0, 0.9 Hz), 7.89 (2H, dd, J = 6.9, 1.8 Hz), 7.55-7.51 (3H, m), 7.45 (1H, d, J = 8.2 Hz), 7.36 (2H, td, J = 7.8, 1.8 Hz), 7.08-7.05 (2H, m), 6.93 (1H, d, J = 8.2 Hz), 6.85 (1H, d, J = 12.4 Hz), 4.00 (2H, t, J = 5.5 Hz), 3.37 (2H, dd, J = 6.9, 4.1 Hz), 3.25 (1H, t, J = 6.9 Hz), 1.26 (6H, d, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 23.2, 30.0, 56.1, 58.3, 121.8, 123.6, 126.2, 126.9, 127.5, 128.2, 128.4, 131.9, 132.3, 135.6, 136.1, 136.1, 137.2, 146.3, 147.5, 149.4, 155.7.
(Z)-4-iso-butyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D18) 1H-NMR (CDCl3) δ: 8.57 (1H, td, J= 2.5, 1.2 Hz), 7.88 (2H, dd, J = 8.7, 1.8 Hz), 7.51 (2H, dt, J = 8.5, 2.1 Hz), 7.45 (1H, dd, J = 8.0, 2.1 Hz), 7.40-7.35 (2H, m), 7.31 (1H, d, J = 7.8 Hz), 7.07 (1H, ddd, J = 7.4, 4.9, 1.0 Hz), 6.99 (2H, dd, J = 13.3, 10.1 Hz), 6.82 (1H, d, J = 12.4 Hz), 4.00 (2H, dd, J = 6.9, 4.1 Hz), 3.50 (1H, br s), 3.38-3.35 (2H, m), 2.59 (2H, d, J= 7.3 Hz), 1.98 (1H, t, J = 6.6 Hz), 0.96 (6H, d, J = 6.4 Hz).; 13C-NMR (CDCl3) δ: 22.5, 29.3, 42.5, 56.1, 58.3, 121.8, 123.5, 126.3, 127.5, 127.6, 128.3, 131.2, 131.6, 132.3,135.6, 136.2, 136.8, 137.2, 140.9, 146.3, 149.4, 155.9.
(Z)-4'-(2-hydroxyethanesulfonyl)-3-(3-methylpyridin-2-yl-2-vinyl)-4-propyl-1,1'-biphenyl (D19) 1H-NMR (CDCl3) δ: 8.49 (1H, dd, J = 4.8, 1.7 Hz), 8.10 (1H, d, J = 15.4 Hz), 8.00 (2H, dt, J = 8.6, 2.0 Hz), 7.86 (4H, ddd, J = 14.8, 9.5, 7.5 Hz), 7.49 (2H, tdd, J = 5.2, 2.6, 1.2 Hz), 7.32 (2H, t, J= 7.6 Hz), 7.11 (1H, dd, J = 7.6, 4.8 Hz), 4.55 (2H, td, J = 6.3, 0.8 Hz), 3.53 (2H, t, J = 6.2 Hz), 2.85 (2H, t, J = 7.7 Hz), 2.46 (3H, s), 1.78 (1H, br s), 1.71 (2H, dd, J = 15.3, 7.4 Hz), 1.01 (3H, t, J= 7.3 Hz).; 13C-NMR (CDCl3) δ: 14.0, 19.0, 24.1, 35.1, 54.9, 57.0, 122.3, 125.1, 126.6, 126.8, 127.9, 128.6, 130.5, 130.9, 131.2, 136.7, 136.9, 137.3, 138.3, 142.2, 147.0, 147.1, 153.3, 160.0.
(Z)-4'-(2-hydroxyethanesulfonyl)-3-(3-penthylpyridin-2-yl-2-vinyl)-4-propyl-1,1'-biphenyl (D21) 1H-NMR (CDCl3) δ: 8.50 (1H, dd, J = 4.7, 1.6 Hz), 8.10 (1H, d, J = 15.4 Hz), 8.00 (2H, dt, J = 8.6, 2.0 Hz), 7.86 (4H, ddd, J = 13.4, 10.0, 7.5 Hz), 7.49 (2H, td, J = 7.6, 1.9 Hz), 7.31 (2H, dd, J= 14.6, 11.7 Hz), 7.13 (1H, dd, J = 7.7, 4.7 Hz), 4.55 (2H, td, J= 6.3, 0.8 Hz), 3.54 (2H, t, J = 6.3 Hz), 2.85 (2H, t, J = 7.7 Hz), 2.76 (2H, t, J = 7.7 Hz), 1.68 (5H, dq, J = 27.8, 6.1 Hz), 1.37 (4H, td, J = 7.1, 3.7 Hz), 1.01 (3H, t, J = 7.2 Hz), 0.89 (3H, dt, J = 8.3, 3.1 Hz).; 13C-NMR (CDCl3) δ: 14.0, 14.0, 22.5, 24.1, 30.5, 31.5, 32.4, 35.2, 54.9, 57.0, 122.3, 125.3, 126.7, 126.7, 127.8, 128.6, 130.5, 131.1, 135.6, 136.7, 137.2, 137.5, 142.2, 147.1, 147.2, 152.9, 160.0.
(Z)-4-heptyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D22) 1H-NMR (CDCl3) δ: 8.57 (1H, dd, J= 3.0, 2.1 Hz), 7.89-7.87 (2H, m), 7.52 (2H, dt, J = 8.7, 1.8 Hz), 7.46 (1H, dd, J = 8.0, 1.6 Hz), 7.37 (3H, td, J = 9.8, 3.8 Hz), 7.09-7.06 (1H, m), 6.99 (2H, dd, J = 15.1, 10.1 Hz), 6.84 (1H, d, J= 12.4 Hz), 4.00 (2H, d, J = 5.0 Hz), 3.38-3.35 (2H, m), 3.33 (1H, s), 2.70 (2H, t, J = 7.8 Hz), 1.67-1.59 (2H, m), 1.39-1.26 (8H, m), 0.87 (3H, t, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 14.0, 22.6, 29.1, 29.4, 30.5, 31.7, 33.3, 56.2, 58.3, 121.8, 123.6, 126.5, 127.5, 128.3, 128.4, 130.2, 131.7, 132.1, 135.6, 136.2, 136.5, 137.1, 142.0, 146.4, 149.4, 155.9.
(Z)-4'-(2-hydroxyethanesulfonyl)-4-octyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D23) 1H-NMR (CDCl3) δ: 8.56 (1H, dd, J= 3.0, 2.1 Hz), 7.88 (2H, d, J = 8.7 Hz), 7.51 (2H, d, J = 8.7 Hz), 7.46 (1H, dd, J = 8.2, 1.8 Hz), 7.40-7.33 (3H, m), 7.09-7.06 (1H, m), 6.99 (2H, dd, J = 13.7, 10.1 Hz), 6.83 (1H, d, J = 12.4 Hz), 4.00 (2H, t, J = 5.7 Hz), 3.66 (1H, s), 3.37 (2H, t, J = 5.7 Hz), 2.69 (2H, t, J = 7.8 Hz), 1.66-1.59 (2H, m), 1.32 (10H, tt, J = 17.9, 5.8 Hz), 0.87 (3H, t, J = 6.6 Hz).; 13C-NMR (CDCl3) δ: 14.0, 22.5, 29.1, 29.3, 29.4, 30.4, 31.7, 33.3, 56.1, 58.3, 121.8, 123.6, 126.5, 127.4, 128.2, 128.3, 130.2, 131.6, 132.1, 135.6, 136.1, 136.4, 137.1, 141.9, 146.2, 149.3, 155.8.
(Z)-4-cyclo-hexyl-4'-(2-hydroxyethanesulfonyl)-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D24) 1H-NMR (CDCl3) δ: 8.54 (1H, d, J= 4.6 Hz), 7.88 (2H, d, J = 8.7 Hz), 7.51 (3H, d, J = 8.7 Hz), 7.42 (1H, d, J = 8.2 Hz), 7.35 (2H, dd, J = 11.4, 5.0 Hz), 7.06 (2H, dd, J = 12.4, 5.0 Hz), 6.93 (1H, d, J = 7.8 Hz), 6.84 (1H, d, J = 12.4 Hz), 4.00 (3H, t, J = 5.7 Hz), 3.38 (2H, t, J= 5.7 Hz), 2.83 (1H, t, J = 11.2 Hz), 1.80 (5H, dd, J = 25.4, 15.3 Hz), 1.51-1.25 (5H, m).; 13C-NMR (CDCl3) δ: 25.9, 26.7, 33.4, 40.5, 55.9, 58.2, 121.7, 123.6, 126.7, 126.7, 127.3, 128.0, 128.2, 131.6, 132.4, 135.6, 135.9, 136.0, 137.2, 146.0, 146.4, 149.1, 155.6.
(Z)-4'-(2-hydroxyethanesulfonyl)-4-cyclo-pentyl-5-(pyridin-2-yl-2-vinyl)-1,1'-biphenyl (D25) 1H-NMR (CDCl3) δ: 8.58 (1H, d, J= 4.1 Hz), 7.89 (2H, dt, J = 8.7, 1.8 Hz), 7.55 (2H, dd, J = 8.7, 1.8 Hz), 7.51 (1H, dd, J = 8.2, 2.3 Hz), 7.46 (1H, d, J = 7.8 Hz), 7.37-7.33 (2H, m), 7.07 (2H, dt, J = 12.4, 3.0 Hz), 6.92 (1H, d, J= 8.2 Hz), 6.85 (1H, d, J = 12.4 Hz), 4.01 (2H, q, J = 5.5 Hz), 3.36 (2H, td, J = 4.1, 2.0 Hz), 3.29 (1H, t, J = 8.5 Hz), 3.04 (1H, s), 2.02 (2H, tt, J = 7.6, 4.0 Hz), 1.86-1.59 (6H, m).; 13C-NMR (CDCl3) δ: 25.6, 34.1, 42.2, 56.3, 58.3, 121.8, 123.7, 126.7, 126.8, 127.6, 128.1, 128.4, 132.0, 132.7, 135.5, 136.1, 137.0, 137.1, 145.5, 146.5, 149.5, 155.9.
(5)E1〜E25の合成
E1〜E25の合成は下記Simons-Smith合成法により合成した。
合成したE1〜E25のNMRを下記に示す。
cis-4'-(2-hydroxyethanesulfonyl)-3-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E1) 1H-NMR (CDCl3) δ: 8.50 (1H, dq, J= 4.9, 0.9 Hz), 7.98 (2H, dt, J = 8.8, 1.9 Hz), 7.77 (2H, dt, J = 8.4, 1.9 Hz), 7.57 (1H, td, J = 7.6, 1.9 Hz), 7.41 (3H, td, J = 3.3, 1.8 Hz), 7.21 (2H, tt, J = 4.4, 1.5 Hz), 7.09 (1H, ddd, J = 7.4, 4.8, 1.1 Hz), 4.04 (2H, t, J = 5.3 Hz), 3.41-3.39 (2H, m), 3.04 (1H, s), 2.62 (1H, ddd, J = 9.5, 5.3, 3.4 Hz), 2.34 (1H, ddd, J = 9.2, 5.0, 3.6 Hz), 1.82 (1H, ddd, J = 9.6, 4.9, 3.9 Hz), 1.54 (1H, ddd, J= 9.7, 5.1, 3.6 Hz).; 13C-NMR (CDCl3) δ: 18.9, 28.0, 29.5, 56.3, 58.3, 120.8, 122.0, 124.9, 125.3, 126.0, 128.1, 128.5, 129.2, 136.0, 137.3, 139.1, 143.3, 147.1, 149.4, 160.7.
cis-2-fluoro-4'-(2-hydroxyethanesulfonyl)-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E2) 1H-NMR (CDCl3) δ: 8.49 (1H, d, J= 4.6 Hz), 8.00 (2H, d, J = 8.2 Hz), 7.76 (2H, d, J = 6.9 Hz), 7.59-7.55 (1H, m), 7.24-7.08 (5H, m), 4.05 (2H, s), 3.40 (2H, t, J = 5.3 Hz), 2.87 (1H, s), 2.62-2.57 (1H, m), 2.30-2.25 (1H, m), 1.78 (1H, td, J= 9.8, 5.3 Hz), 1.47 (1H, dt, J = 10.2, 4.4 Hz).; 13C-NMR (CDCl3) δ: 18.8, 27.1, 29.3, 56.4, 58.3, 116.3 (d, J = 23.0 Hz), 120.9, 122.0, 126.7 (d, J = 13.4 Hz), 127.7 (d, J = 7.7 Hz), 128.1, 128.2 (d, J = 2.9 Hz), 130.0 (d, J = 2.9 Hz), 136.0, 137.7,138.8 (d, J = 3.8 Hz), 141.9, 149.4, 159.3, 160.5.
cis-4'-(2-hydroxyethanesulfonyl)-3-(2-(6-methylpyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E3) 1H-NMR (CDCl3) δ: 7.98 (2H, d, J = 8.2 Hz), 7.78 (2H, dd, J = 6.9, 1.8 Hz), 7.43 (4H, dt, J = 17.6, 5.2 Hz), 7.22-7.20 (1H, m), 6.95 (2H, t, J = 7.1 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.41-3.38 (2H, m), 2.96 (1H, s), 2.59-2.55 (1H, m), 2.51 (3H, s), 2.34 (1H, ddd, J = 9.2, 5.0, 3.7 Hz), 1.79 (1H, dt, J = 9.6, 4.6 Hz), 1.50 (1H, ddd, J = 9.5, 4.9, 3.8 Hz).; 13C-NMR (CDCl3) δ: 18.9, 24.6, 27.8, 29.7, 56.3, 58.3, 118.1, 120.3, 124.8, 125.3, 126.0, 128.1, 128.4, 129.1, 136.2, 137.2, 139.0, 143.5, 147.2, 158.0, 160.0.
cis-2-fluoro-4'-(2-hydroxyethanesulfonyl)-5-(2-(6-methylpyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E4) 1H-NMR (CDCl3) δ: 7.98 (2H, d, J = 8.2 Hz), 7.78 (2H, dd, J = 6.9, 1.8 Hz), 7.43 (4H, dt, J = 17.6, 5.2 Hz), 7.22-7.20 (1H, m), 6.95 (2H, t, J = 7.1 Hz), 4.04 (2H, t, J = 5.5 Hz), 3.41-3.38 (2H, m), 2.96 (1H, s), 2.59-2.55 (1H, m), 2.51 (3H, s), 2.34 (1H, ddd, J = 9.2, 5.0, 3.7 Hz), 1.79 (1H, dt, J = 9.6, 4.6 Hz), 1.50 (1H, ddd, J = 9.5, 4.9, 3.8 Hz).; 13C-NMR (CDCl3) δ: 18.7, 24.5, 26.9, 29.4, 56.3, 58.3, 116.2 (d, J = 22.0 Hz), 118.0, 120.3, 126.6 (d, J = 13.4 Hz), 127.6 (d, J = 8.6 Hz), 128.1 (d, J = 10.5 Hz), 128.2 (d, J = 2.9 Hz), 129.9 (d, J = 2.9 Hz), 136.2, 137.7, 138.9 (d, J= 3.8 Hz), 141.9 (d, J = 1.9 Hz), 156.7, 158.0, 159.2, 159.8.; 19F-NMR (CDCl3) δ: -22.0.
cis-3-tert-butyl-4'-(2-hydroxyethanesulfonyl)-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E5) 1H-NMR (CDCl3) δ: 8.50 (1H, d, J= 4.6 Hz), 7.98 (2H, t, J = 4.4 Hz), 7.77 (2H, dd, J = 6.9, 1.8 Hz), 7.56 (1H, td, J = 7.8, 1.8 Hz), 7.42 (1H, t, J = 1.8 Hz), 7.29 (1H, t, J = 1.8 Hz), 7.21 (1H, t, J = 3.9 Hz), 7.17 (1H, t, J= 1.6 Hz), 7.08 (1H, ddd, J = 7.4, 4.9, 1.3 Hz), 4.04 (2H, d, J = 5.0 Hz), 3.41-3.38 (2H, m), 2.96 (1H, s), 2.64-2.60 (1H, m), 2.37-2.32 (1H, m), 1.81 (1H, dt, J = 9.6, 4.4 Hz), 1.55 (1H, ddd, J = 9.7, 4.9, 3.5 Hz), 1.37 (9H, s).; 13C-NMR (CDCl3) δ: 19.0, 28.2, 29.5, 31.3, 34.9, 56.4, 58.4, 120.8, 121.9, 122.0, 122.3, 124.0, 128.2, 128.4, 136.0, 137.2, 139.0, 142.9, 147.9, 149.4, 152.2, 160.8.
cis-4'-(2-hydroxyethanesulfonyl)-3-methyl-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E6) 1H-NMR (CDCl3) δ: 8.38-8.37 (1H, m), 7.90 (2H, t, J = 4.4 Hz), 7.53 (2H, dd, J = 6.9, 1.8 Hz), 7.40 (1H, td, J = 7.8, 1.8 Hz), 7.07 (1H, s), 6.98-6.92 (4H, m), 4.02 (2H, t, J = 5.5 Hz), 3.38 (2H, dd, J = 6.9, 4.1 Hz), 3.32 (1H, s), 2.72 (1H, td, J = 8.9, 6.4 Hz), 2.61 (1H, dd, J = 15.8, 8.9 Hz), 2.27 (3H, s), 1.85 (1H, q, J = 6.1 Hz), 1.55 (1H, td, J = 8.6, 5.3 Hz).; 13C-NMR (CDCl3) δ: 11.0, 21.2, 25.3, 26.2, 56.2, 58.3, 120.7, 123.4, 125.1, 125.6, 127.8, 128.2, 128.6, 130.6, 132.0, 135.5, 137.0, 138.0, 138.8, 147.2, 148.5, 158.0.
cis-4'-(2-hydroxyethanesulfonyl)-4-methyl-3-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E8) 1H-NMR (CDCl3) δ: 8.29-8.27 (1H, m), 7.95 (2H, dt, J = 8.5, 2.1 Hz), 7.67 (2H, dt, J = 8.7, 1.8 Hz), 7.36 (1H, d, J = 1.8 Hz), 7.31 (1H, td, J = 7.8, 1.8 Hz), 7.25 (1H, dd, J = 8.2, 2.7 Hz), 7.05 (1H, d, J = 8.2 Hz), 6.90 (1H, ddd, J = 7.4, 4.9, 1.0 Hz), 6.76 (1H, d, J = 8.2 Hz), 4.04 (2H, s), 3.39 (2H, td, J = 4.1, 2.1 Hz), 3.06 (1H, s), 2.78 (1H, td, J= 8.7, 6.0 Hz), 2.58 (1H, q, J = 8.2 Hz), 2.25 (3H, s), 1.89 (1H, dd, J= 12.4, 5.5 Hz), 1.60 (1H, td, J = 8.5, 5.2 Hz).; 13C-NMR (CDCl3) δ: 11.1, 19.4, 25.0, 25.3, 56.4, 58.4, 120.5,121.7, 125.0, 127.7, 128.4, 128.4, 130.0, 135.3, 135.6, 136.5, 136.8, 139.6, 147.2, 148.4, 158.4.
cis-4'-(2-hydroxyethanesulfonyl)-3-(2-(3-methylpyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E9) 1H-NMR (CDCl3) δ: 8.35 (1H, t, J = 2.5 Hz), 7.99 (2H, dt, J = 8.5, 1.9 Hz), 7.79 (2H, dt, J = 8.7, 1.8 Hz), 7.41 (4H, tt, J = 8.2, 1.7 Hz), 7.27-7.23 (1H, m), 7.00 (1H, dd, J = 7.6, 4.8 Hz), 4.05 (2H, q, J = 5.5 Hz), 3.40 (2H, td, J = 4.1, 2.0 Hz), 2.78 (1H, t, J= 6.2 Hz), 2.64 (1H, ddd, J = 9.5, 5.2, 3.8 Hz), 2.41 (1H, td, J= 5.5, 4.7 Hz), 2.39 (1H, s), 1.89 (1H, ddd, J = 9.4, 4.8, 3.9 Hz), 1.52 (1H, ddd, J = 9.5, 4.9, 3.5 Hz).; 13C-NMR (CDCl3) δ: 12.5, 25.6, 26.2, 27.4, 58.4, 64.0, 120.5, 125.4, 126.1, 128.2, 131.6, 132.7, 137.0, 139.0, 146.7.
cis-4'-(2-hydroxyethanesulfonyl)-3-(2-(6-methylpyridin-2-yl)cyclopropyl)-4-methyl-1,1'-biphenyl (E10) 1H-NMR (CDCl3) δ: 7.95 (2H, dt, J = 8.7, 2.1 Hz), 7.68 (2H, dt, J = 8.7, 1.8 Hz), 7.40 (1H, d, J = 1.8 Hz), 7.24 (1H, dd, J = 7.8, 1.8 Hz), 7.17 (1H, t, J = 7.8 Hz), 7.04 (1H, d, J = 7.8 Hz), 6.74 (1H, d, J = 7.3 Hz), 6.48 (1H, d, J = 7.8 Hz), 4.05-4.03 (2H, m), 3.42-3.39 (2H, m), 3.30 (1H, br s), 2.74 (1H, td, J = 8.7, 6.0 Hz), 2.54 (1H, q, J = 8.2 Hz), 2.30 (3H, s), 2.22 (3H, s), 1.86 (1H, dd, J= 12.4, 6.0 Hz), 1.56 (1H, td, J = 8.6, 5.2 Hz).; 13C-NMR (CDCl3) δ: 11.2, 19.4, 24.2, 24.9, 25.2, 56.2, 58.3, 118.2, 119.8, 124.8, 127.6, 128.3, 128.5, 129.9, 135.4, 135.5, 136.7,136.8, 139.6, 147.2, 156.7, 157.6.
cis-4'-(2-hydroxyethanesulfonyl)-3-(2-(3-methylpyridin-2-yl)cyclopropyl)-4-methyl-1,1'-biphenyl (E11) 1H-NMR (CDCl3) δ: 8.36 (1H, d, J = 4.6 Hz), 8.00-7.97 (2H, m), 7.78 (2H, dt, J = 8.7, 1.8 Hz), 7.40 (3H, td, J = 7.3, 6.4 Hz), 7.27 (2H, t, J= 5.3 Hz), 7.01 (1H, dd, J = 7.6, 4.8 Hz), 4.04 (2H, t, J = 5.3 Hz), 3.40 (2H, td, J = 4.1, 2.0 Hz), 2.93 (1H, s), 2.71 (1H, dt, J= 9.8, 4.4 Hz), 2.42 (3H, s), 2.38 (3H, s), 2.30 (1H, dt, J = 9.3, 4.2 Hz), 1.81-1.76 (1H, m), 1.54 (1H, ddd, J = 9.3, 5.4, 3.1 Hz).; 13C-NMR (CDCl3) δ: 16.8, 19.0, 19.5, 23.7, 25.7, 56.4, 58.4, 120.4, 124.8, 125.0, 127.8, 128.5, 130.5, 130.6, 136.5, 137.0, 137.1, 139.1, 141.3, 146.8, 147.3, 159.0.
cis-4'-(2-hydroxyethanesulfonyl)-2-methyl-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E12) 1H-NMR (CDCl3) δ: 8.36 (1H, dd, J= 4.9, 0.9 Hz), 7.91 (2H, dt, J = 8.3, 1.8 Hz), 7.41 (1H, td, J = 7.7, 1.8 Hz), 7.30-7.27 (2H, m), 7.02-6.97 (3H, m), 6.90 (1H, d, J = 8.0 Hz), 6.79 (1H, s), 4.05 (2H, t, J = 5.7 Hz), 3.67 (1H, s), 3.43-3.40 (2H, m), 2.68 (1H, td, J = 8.8, 6.4 Hz), 2.62-2.55 (1H, m), 2.10 (3H, s), 1.77 (1H, dd, J = 11.8, 6.3 Hz), 1.51 (1H, td, J = 8.5, 5.4 Hz).; 13C-NMR (CDCl3) δ: 10.8, 19.7, 24.9, 26.0, 56.1, 58.2, 120.6, 123.3, 127.6, 129.1, 130.0, 130.0, 130.0, 132.2, 135.5, 135.6, 137.0, 138.7, 148.0, 148.4, 158.0.
cis-4'-(2-hydroxyethanesulfonyl)-4-propyl-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E14) 1H-NMR (CDCl3) δ: 8.29 (1H, dt, J= 5.0, 0.9 Hz), 7.94 (2H, dt, J = 8.6, 1.9 Hz), 7.66 (2H, dt, J = 8.6, 1.9 Hz), 7.35-7.27 (4H, m), 7.08 (1H, d, J = 8.0 Hz), 6.91 (1H, ddd, J = 7.4, 5.0, 1.0 Hz), 6.75 (1H, d, J = 8.0 Hz), 4.04 (2H, t, J = 5.4 Hz), 3.40 (2H, dt, J = 9.6, 3.7 Hz), 3.13 (1H, d, J= 3.1 Hz), 2.81-2.60 (3H, m), 2.54-2.46 (1H, m), 1.90 (1H, dd, J = 12.6, 5.7 Hz), 1.66-1.57 (2H, m), 1.45 (1H, ddt, J = 16.9, 9.7, 3.6 Hz), 0.94 (3H, t, J = 7.3 Hz).; 13C-NMR (CDCl3) δ: 11.4, 14.1, 23.0, 24.4, 25.8, 34.3, 56.3, 58.3, 120.5, 121.9, 125.0, 127.7, 128.3, 128.5, 129.0, 135.3, 135.3, 135.9, 136.7, 143.8, 147.2, 148.3, 158.4.
cis-4'-(2-hydroxyethanesulfonyl)-4-pentyl-3-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E16) 1H-NMR (CDCl3) δ: 1H-NMR (CDCl3) δ: 8.28 (1H, dq, J = 5.0, 0.9 Hz), 7.94 (2H, dt, J = 8.5, 2.0 Hz), 7.65 (2H, dt, J = 8.8, 1.9 Hz), 7.35 (1H, d, J = 1.9 Hz), 7.29 (2H, tt, J = 10.3, 3.4 Hz), 7.08 (1H, t, J = 4.0 Hz), 6.89 (1H, ddd, J = 7.3, 4.9, 1.0 Hz), 6.74 (1H, t, J = 4.0 Hz), 4.04-4.02 (2H, m), 3.39 (2H, td, J = 4.1, 2.3 Hz), 3.25 (1H, br s), 2.80-2.69 (2H, m), 2.63 (1H, dd, J = 16.0, 8.8 Hz), 2.55-2.48 (1H, m), 1.92-1.88 (1H, m), 1.63-1.51 (2H, m), 1.45-1.27 (5H, m), 0.90 (3H, dd, J= 9.0, 5.1 Hz).; 13C-NMR (CDCl3) δ: 11.4, 14.0, 22.5, 24.4, 25.8, 29.7, 31.8, 32.2, 56.3, 58.4, 120.5, 121.9, 125.0, 127.6, 128.3, 128.6, 128.9, 135.2, 135.3, 135.8, 136.9, 144.0, 147.1, 148.3,158.4.
cis-4'-(2-hydroxyethanesulfonyl)-4-iso-propyl-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E17) 1H-NMR (CDCl3) δ: 8.30-8.29 (1H, m), 7.96 (2H, dt, J = 8.5, 2.1 Hz), 7.72 (2H, dt, J = 8.5, 1.9 Hz), 7.46 (1H, d, J = 1.4 Hz), 7.36 (1H, dd, J = 8.0, 2.1 Hz), 7.31-7.27 (1H, m), 7.16 (1H, d, J = 8.2 Hz), 6.89 (1H, ddd, J = 7.6, 4.8, 1.1 Hz), 6.65 (1H, d, J = 7.8 Hz), 4.04 (2H, q, J = 5.5 Hz), 3.39 (3H, ddd, J = 12.6, 7.8, 5.3 Hz), 2.81 (2H, dq, J = 20.0, 5.6 Hz), 2.64 (1H, dd, J = 16.0, 8.7 Hz), 1.87 (1H, dd, J = 12.4, 6.0 Hz), 1.63 (2H, td, J = 8.5, 5.2 Hz), 1.18 (3H, d, J = 6.9 Hz), 0.79 (3H, d, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 11.7, 22.5, 24.2, 24.6, 25.9, 28.6, 56.5, 58.4, 120.5, 121.4, 125.5, 125.6, 127.8, 128.4, 129.1, 135.0,135.2, 135.4, 136.8, 147.3, 148.5, 150.2, 158.5.
cis-4'-(2-hydroxyethanesulfonyl)-3-(2-(3-methylpyridin-2-yl)cyclopropyl)-4-propyl-1,1'-biphenyl (E19) 1H-NMR (CDCl3) δ: 8.37 (1H, d, J = 3.2 Hz), 7.99 (2H, dd, J = 6.7, 1.9 Hz), 7.80-7.78 (2H, m), 7.41 (2H, tt, J = 4.9, 1.8 Hz), 7.35 (1H, d, J = 1.9 Hz), 7.28 (1H, d, J = 7.8 Hz), 7.01 (1H, dd, J = 7.5, 4.9 Hz), 4.05 (2H, s), 3.41-3.39 (2H, m), 2.79 (2H, dt, J = 9.7, 4.3 Hz), 2.72 (2H, dd, J = 11.1, 4.6 Hz), 2.40 (3H, s), 2.30 (1H, dt, J= 9.4, 4.3 Hz), 1.80-1.76 (1H, m), 1.57 (2H, ddd, J = 10.8, 6.8, 4.4 Hz), 0.86 (3H, t, J = 7.3 Hz).; 13C-NMR (CDCl3) δ: 14.1, 17.0, 18.9, 23.6, 24.4, 25.1, 34.9, 56.5, 58.4, 120.4, 124.6, 125.0, 127.9, 128.5, 129.8, 130.7, 136.5, 137.0, 137.1, 140.8, 143.4, 146.8, 147.4, 159.0.
cis-4'-(2-hydroxyethanesulfonyl)-3-(2-(3-penthylpyridin-2-yl)cyclopropyl)-4-propyl-1,1'-biphenyl (E21) 1H-NMR (CDCl3) δ: 8.37 (1H, dd, J = 4.8, 1.7 Hz), 7.99 (2H, dt, J = 8.6, 2.0 Hz), 7.79 (2H, dt, J = 8.6, 1.9 Hz), 7.41 (2H, dd, J = 7.8, 1.9 Hz), 7.31 (2H, dd, J = 26.8, 4.9 Hz), 7.02 (1H, dd, J = 7.6, 4.8 Hz), 4.05 (2H, s), 3.41-3.39 (2H, m), 2.85 (1H, s), 2.81 (1H, dt, J= 9.7, 4.4 Hz), 2.75-2.66 (4H, m), 2.34 (1H, dt, J = 9.4, 4.3 Hz), 1.80-1.75 (1H, m), 1.65-1.52 (5H, m), 1.34-1.22 (4H, m), 0.84 (6H, dt, J= 17.3, 7.2 Hz).; 13C-NMR (CDCl3) δ: 13.9, 14.1, 17.3, 22.5, 23.7, 24.1, 25.1, 30.2, 31.6, 32.5, 34.9, 56.4, 58.4, 120.4, 124.5, 124.9, 127.9, 128.5, 129.8, 135.3, 136.3, 136.5, 137.0, 140.9, 143.4, 146.8, 147.3, 158.4.
cis-4-heptyl-4'-(2-hydroxyethanesulfonyl)-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E22) 1H-NMR (CDCl3) δ: 8.28 (1H, d, J= 4.6 Hz), 7.94 (2H, d, J = 8.2 Hz), 7.65 (2H, d, J = 8.7 Hz), 7.31 (4H, tt, J = 11.9, 4.5 Hz), 7.08 (1H, d, J = 7.8 Hz), 6.90 (1H, dd, J = 6.9, 5.0 Hz), 6.74 (1H, d, J = 8.2 Hz), 4.03 (2H, s), 3.39 (3H, dd, J = 10.3, 4.8 Hz), 2.80-2.69 (2H, m), 2.63 (1H, dd, J= 16.3, 8.5 Hz), 2.55-2.48 (1H, m), 1.89 (1H, q, J = 6.0 Hz), 1.63-1.52 (2H, m), 1.35 (9H, tt, J = 25.4, 7.9 Hz), 0.89 (3H, t, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 11.4, 14.1, 22.6, 24.4, 25.7, 29.2, 29.6, 30.0, 31.7, 32.3, 56.2, 58.3, 120.5, 121.9, 125.0, 127.6, 128.3, 128.6, 128.9, 135.3, 135.3, 135.7, 136.8, 144.0, 147.1, 148.3, 158.4.
cis-4'-(2-hydroxyethanesulfonyl)-4-octyl-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E23) 1H-NMR (CDCl3) δ: 8.29 (1H, dt, J= 4.3, 1.5 Hz), 7.96-7.93 (2H, m), 7.66 (2H, dt, J = 8.7, 1.8 Hz), 7.35-7.27 (3H, m), 7.08 (1H, d, J = 8.2 Hz), 6.90 (1H, ddd, J = 7.3, 5.0, 0.9 Hz), 6.75 (1H, d, J = 7.8 Hz), 4.03 (2H, s), 3.41-3.38 (2H, m), 3.18 (1H, s), 2.80-2.69 (2H, m), 2.63 (1H, q, J = 8.2 Hz), 2.55-2.48 (1H, m), 1.90 (1H, dd, J = 12.4, 6.0 Hz), 1.58 (2H, dtd, J= 23.2, 7.9, 4.7 Hz), 1.43-1.24 (11H, m), 0.89 (3H, t, J = 6.9 Hz).; 13C-NMR (CDCl3) δ: 11.4, 14.1, 22.6, 24.4, 25.8, 29.2, 29.5, 29.7, 30.0, 31.8, 32.3, 56.3, 58.3, 120.5, 121.9, 125.0, 127.7, 128.3, 128.6, 129.0, 135.2, 135.3, 135.8, 136.7, 144.1, 147.1, 148.3, 158.4.
cis-4-cyclo-hexyl-4'-(2-hydroxyethanesulfonyl)-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E24) 1H-NMR (CDCl3) δ: 8.28-8.27 (1H, m), 7.96 (2H, dt, J = 8.7, 1.8 Hz), 7.73 (2H, dt, J = 8.5, 2.1 Hz), 7.49 (1H, d, J = 1.8 Hz), 7.36 (1H, dd, J = 8.0, 2.1 Hz), 7.29 (2H, td, J = 7.7, 1.7 Hz), 7.12 (1H, d, J = 8.2 Hz), 6.90 (1H, ddd, J = 7.4, 4.9, 1.0 Hz), 6.65 (1H, d, J = 8.2 Hz), 4.04 (2H, d, J = 5.0 Hz), 3.41-3.38 (2H, m), 3.03 (1H, s), 2.94 (1H, t, J = 11.7 Hz), 2.80 (1H, td, J = 8.7, 6.0 Hz), 2.62 (1H, dd, J = 16.0, 8.7 Hz), 1.86-1.61 (7H, m), 1.49-1.17 (5H, m), 0.67 (1H, d, J = 12.8 Hz).; 13C-NMR (CDCl3) δ: 11.8, 24.7, 25.9, 26.2, 26.7, 27.1, 32.7, 34.7, 39.4, 56.4, 58.4, 120.5, 121.3, 125.5, 126.2, 127.7, 128.4, 129.3, 135.1, 135.3, 136.7, 147.2, 148.4, 149.1, 158.5.
cis-4'-(2-hydroxyethanesulfonyl)-4-cyclo-pentyl-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (E25) 1H-NMR (CDCl3) δ: 8.29 (1H, t, J = 2.3 Hz), 7.95 (2H, t, J = 4.1 Hz), 7.70 (2H, t, J = 4.4 Hz), 7.44 (1H, d, J = 1.8 Hz), 7.35 (1H, dd, J = 8.0, 2.1 Hz), 7.31-7.27 (1H, m), 7.17 (1H, d, J = 8.2 Hz), 6.90 (1H, ddd, J = 7.4, 4.9, 1.0 Hz), 6.62 (1H, d, J = 7.8 Hz), 4.04 (2H, t, J = 5.3 Hz), 3.45-3.39 (3H, m), 3.34 (1H, d, J = 16.9 Hz), 2.78 (1H, td, J = 8.7, 6.0 Hz), 2.66 (1H, q, J = 8.2 Hz), 2.12-2.04 (1H, m), 1.85-1.61 (6H, m), 1.46-1.23 (3H, m).; 13C-NMR (CDCl3) δ: 12.0, 24.8, 25.8, 25.8, 25.9, 33.8, 35.2, 40.6, 56.3, 58.3, 120.5, 121.3, 125.5, 126.1, 127.6, 128.3, 128.4, 128.8, 132.0, 135.2, 135.2, 135.7, 136.8, 147.0, 148.1, 148.3, 158.6.
(6)F1〜F25の合成
F1〜F25の合成は下記Simons-Smith合成法により合成した。
合成したF1〜F25においてF14のNMRを下記に示す。
trans-4'-(2-hydroxyethanesulfonyl)-4-propyl-5-(2-(pyridin-2-yl)cyclopropyl)-1,1'-biphenyl (F14) 1H-NMR (CDCl3) δ: 8.52 (1H, dq, J= 4.9, 0.9 Hz), 7.98 (2H, dt, J = 8.6, 2.0 Hz), 7.78 (2H, dt, J = 8.6, 2.0 Hz), 7.59 (1H, td, J = 7.6, 1.9 Hz), 7.40 (1H, dd, J = 7.9, 2.0 Hz), 7.33-7.26 (3H, m), 7.23 (1H, dt, J = 7.8, 1.0 Hz), 7.10 (1H, ddd, J = 7.4, 5.0, 1.1 Hz), 4.04 (2H, s), 3.41-3.38 (2H, m), 2.84 (1H, s), 2.70 (3H, dt, J = 12.6, 5.4 Hz), 2.21 (1H, dt, J = 9.3, 4.3 Hz), 1.77 (1H, ddd, J = 9.3, 4.9, 4.0 Hz), 1.65-1.55 (4H, m), 0.86 (3H, t, J = 7.3 Hz).; 13C-NMR (CDCl3) δ: 14.1, 17.1, 23.7, 25.8, 28.0, 35.0, 56.4, 58.4, 120.7, 121.9, 124.7, 125.1, 127.9, 128.5, 129.8, 136.0, 136.5, 137.0, 140.4, 143.4, 147.3, 149.5, 161.0.
(7)CERT結合親和性、及び、CERT機能阻害性
本実施例にかかる化合物について、表面プラズモン共鳴法(SPR法)によりCERTとの結合親和性を調べた。光学異性体が存在する化合物ではラセミ体について測定した。結合の強さは解離定数Kd(dissociation constant、単位:μM)で示され、この値が小さいほど結合が強いことを示す。Kdは下記表1及び表2において各セル中の上段に記載する。
本実施例にかかる化合物について、無血清培養HeLa細胞における放射性セリンを用いたSM(スフィンゴミエリン)代謝標識率により、CERT機能阻害性を調べた。光学異性体が存在する化合物ではラセミ体について測定した。SM代謝標識率は、化合物無添加時に対する1μM化合物存在時の相対値により調べた。SM代謝標識率は、下記表1及び表2において各セル中の下段に記載する。
表1及び表2の結果から、E16及びE25が、優れたCERT結合親和性及びCERT機能阻害性を示すことが判明した。
(8)異性体
E16及びE25は、優れたCERT結合親和性及びCERT機能阻害性を示したが、それらについて光学異性体ごとのCERT結合親和性及びCERT機能阻害性を調べた。光学異性体の分離は株式会社ダイセルのCHIRALPAK IA-3を使用した。
E16の一方の異性体であるE16-A(1S,2R)は下記である。
E16の他方の異性体であるE16-B(1R,2S)は下記である。
E25の一方の異性体であるE25-A(1S,2R)は下記である。
E25の他方の異性体であるE25-B(1R,2S)は下記である。
各光学異性体の旋光(optical rotation)は下記であった。
(+)-E16-A: HPLC (hexane / iPrOH = 6/4, flow rate = 1.0 ml / min, UV detection at 254 nm) tR= 6.7 min.; [a]D 33.3 = +109.0 (c 1.32, CHCl3)
(-)-E16-B: HPLC (hexane / iPrOH = 6/4, flow rate = 1.0 ml / min, UV detection at 254 nm) tR= 9.5 min.; [a]D 33.8 = -106.5 (c 1.26, CHCl3)
(+)-E25-A: HPLC (hexane / iPrOH = 6/4, flow rate = 1.0 ml / min, UV detection at 254 nm) tR= 8.4 min.; [a]D 34.3 = +102.9 (c 1.32, CHCl3)
(-)-E25-B: HPLC (hexane / iPrOH = 6/4, flow rate = 1.0 ml / min, UV detection at 254 nm) tR= 13.3 min.; [a]D 34.2 = -102.3 (c 1.12, CHCl3)
SPR法によりCERTとの結合親和性を調べた。結果を下記表3に示す。
10%血清含有培地中にて代謝標識解析を行い、CERT機能阻害性を調べた。結果を下記表4に示す。
更に、E16及びE25について光学異性体ごとに、10%血清培養HeLa細胞における放射性セリンを用いたSM代謝標識率により、CERT機能阻害性を調べた。結果を図1及び表5に示す。
上記結果から、E16-A及びE-25Aは、優れたCERT結合親和性及びCERT機能阻害性を示すことが判明した。